rfhg_12151.1

Basic information about the TSS

---

TSS ID: rfhg_12151.1 Species: human Chr: chr1		Start: 150234670 End: 150234684 Strand: -
Source datasets	FANTOM5|EPD
Protocol	CAGE|TSS_database
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2221044,EH38E1383450)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000616917.4:0 AK095228:0 GeneID: 81611 HGNC/MGI_ID: HGNC:16673 UniProt_ID: Q9BTT0 Nearer transcript ids and distances: LF352595:-173 MA588172:-173 view more...

Gene_name: acidic nuclear phosphoprotein 32 family member E Gene_symbol: ANP32E Gene_synonyms: LANP-L LANPL MGC5350 Gene_source: HGNC:16673

TATA-Box annotation

---

Distance to TSS:	1
Nearest PromoterID:	NM_001136479
Entrez ID:	81611
Nearest Unigene:	Hs.656466
Nearest Refseq:	NM_030920
Nearest Ensembl:	ENSG00000143401
Gene Name:	acidic nuclear phosphoprotein 32 family member E
Gene Alias:	LANP-L|LANPL
Gene Type:	protein-coding
CpG%:	0.142857
GC%:	0.600000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ANP32E p2@ANP32E p4@ANP32E p5@ANP32E p6@ANP32E p7@ANP32E p8@ANP32E p9@ANP32E p10@ANP32E
Sample		p1@ANP32E	p2@ANP32E	p4@ANP32E	p5@ANP32E	p6@ANP32E	p7@ANP32E	p8@ANP32E	p9@ANP32E	p10@ANP32E
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.60	5.65	3.70	1.75	4.29	0.58	0.39	0.00	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.02	5.46	5.26	2.23	3.24	2.02	0.00	0.20	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	23.73	5.40	6.94	1.16	6.37	2.31	0.58	0.39	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.08	5.41	4.16	1.04	4.99	1.25	0.42	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.22	4.72	4.05	1.12	3.37	1.12	0.67	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	31.40	3.88	3.88	1.94	4.26	2.13	0.19	0.00	2.33
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	31.59	7.84	7.84	1.96	8.06	1.96	0.22	0.00	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.53	6.54	3.63	3.39	6.78	1.45	0.24	0.00	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	21.80	6.20	5.98	1.28	3.21	1.50	0.64	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	21.45	4.06	4.06	1.74	8.11	1.16	0.00	0.00	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.47	4.85	3.23	0.81	6.47	0.81	1.62	0.40	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	22.77	5.29	1.63	2.03	6.10	3.25	0.00	0.81	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	4.84	3.06	0.97	2.74	1.29	0.32	0.48	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	4.66	2.86	2.56	2.41	1.80	1.05	0.30	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.15	2.85	2.42	1.10	0.88	0.66	0.66	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	3.52	3.27	1.51	0.75	1.76	0.50	0.00	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.15	3.06	2.40	1.09	1.31	0.00	0.44	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	2.11	2.53	1.69	1.27	0.84	0.00	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	1.60	1.07	2.67	1.60	1.07	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.06	3.61	3.16	1.65	1.20	0.75	0.30	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	5.35	3.21	2.00	1.20	1.07	0.27	0.53	0.27	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	5.70	2.59	1.73	1.55	1.38	0.69	0.17	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.39	2.71	1.94	1.55	1.42	0.90	0.39	0.00	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	4.61	3.40	3.40	2.18	1.94	0.73	0.49	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.48	3.10	1.81	2.32	1.55	0.26	0.52	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	4.75	3.48	1.27	0.63	3.80	0.00	0.32	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3.85	3.85	3.85	1.65	1.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	7.54	4.24	2.12	0.94	1.41	0.94	0.24	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	3.55	2.26	2.10	1.45	1.62	0.32	0.16	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.24	3.98	2.90	2.17	0.72	0.36	0.72	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	4.81	2.51	3.14	1.26	1.88	0.42	0.42	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	4.30	2.15	2.34	1.37	1.95	0.00	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.59	2.32	2.53	0.42	0.84	0.42	0.21	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.10	2.31	3.13	2.31	2.14	0.33	0.16	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	6.36	2.99	1.68	1.50	1.50	0.56	0.37	0.37	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	3.83	3.07	2.87	0.38	1.34	1.15	0.38	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.54	1.64	2.04	1.02	1.43	0.00	0.20	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	4.84	1.81	1.01	1.41	1.01	0.81	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.48	1.62	3.51	1.35	2.43	0.54	0.00	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.72	2.16	0.96	0.96	2.16	0.96	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.88	2.59	2.12	1.65	0.94	0.47	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.76	2.49	1.46	1.46	1.76	0.29	0.44	0.15	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	4.22	1.69	1.90	1.27	1.27	0.21	0.21	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.77	1.92	1.57	0.52	0.70	0.17	0.17	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.83	1.00	1.20	1.20	1.81	0.40	0.60	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.68	2.33	2.79	1.16	1.40	0.47	0.23	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	5.04	1.44	1.92	1.68	0.96	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	6.56	1.79	0.60	0.30	0.89	0.30	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.70	1.20	1.44	0.72	1.91	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.05	1.21	2.02	0.61	0.61	0.81	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	5.33	0.82	2.46	0.61	1.23	0.00	0.20	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.23	0.67	2.00	0.22	0.89	0.67	0.67	0.00	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	321.82	41.98	69.96	0.00	0.00	27.98	0.00	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	4.97	0.35	2.13	0.00	2.13	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.30	1.33	0.99	0.66	0.99	0.00	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	67.11	10.07	5.87	3.36	5.03	0.00	0.84	1.68	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.53	2.30	2.76	0.46	1.38	0.00	0.92	0.00	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.16	1.62	0.97	0.32	1.94	0.00	0.00	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	3.53	2.25	0.64	1.93	0.32	0.00	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.14	5.34	3.14	1.57	2.83	0.63	0.00	0.63	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	2.82	0.71	1.41	1.41	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.05	0.00	1.68	0.00	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	38.21	8.76	5.57	1.59	9.55	2.39	0.80	0.00	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.23	2.38	1.70	0.34	1.36	0.34	0.00	0.34	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	3.90	0.97	1.62	0.97	2.27	0.00	0.32	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	4.97	1.77	2.13	1.42	1.42	0.35	0.00	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	662.72	113.15	145.48	48.49	80.82	0.00	0.00	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	623.90	31.59	86.87	23.69	71.08	7.90	0.00	7.90	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	1.95	3.41	0.98	0.49	0.00	0.00	0.98	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.41	2.98	0.99	0.99	2.48	0.99	0.99	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	1.88	3.75	0.00	3.28	0.00	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.25	5.30	0.99	0.99	0.99	0.33	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.26	3.09	4.33	0.93	1.24	0.31	0.31	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	6.11	2.45	1.53	0.92	1.53	0.61	0.31	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	9.19	2.53	1.11	0.95	0.79	0.63	0.32	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	8.82	1.44	1.12	1.60	0.48	0.00	0.16	0.32	0.32
Adipocyte - omental, donor1	11473-119C6	10.94	2.67	1.53	0.64	0.64	1.02	1.02	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	7.47	2.99	0.00	1.49	0.75	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	6.03	2.01	0.33	0.00	0.00	0.00	0.67	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	7.66	1.28	0.00	0.00	1.91	0.64	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	1.10	1.10	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.61	0.90	0.00	0.00	0.00	0.90	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	3.13	0.87	0.52	0.52	0.35	0.35	0.35	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	17.01	4.89	2.93	3.91	1.17	1.17	0.78	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	6.69	4.38	2.32	1.29	0.77	0.00	0.00	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	13.66	3.90	1.12	1.95	0.56	0.28	1.95	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	15.28	2.94	3.53	4.11	3.53	2.35	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	17.70	3.38	2.17	1.53	0.64	1.37	1.77	0.08	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	10.33	2.90	1.29	1.29	0.32	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	6.93	1.60	0.00	1.07	0.00	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	16.14	1.67	1.67	0.56	0.00	0.56	1.11	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	6.65	0.83	0.42	0.42	0.42	0.83	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	6.78	1.51	0.75	1.00	0.50	0.00	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	0.98	0.65	0.33	0.33	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.61	2.44	1.52	0.61	0.30	0.91	1.52	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	19.89	2.21	1.33	1.33	0.44	0.88	0.22	0.22	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	2.87	1.08	0.36	0.36	0.00	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	1.20	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.99	1.62	0.90	1.80	0.90	1.80	0.72	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	1.67	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.40	2.26	0.62	0.41	0.00	0.62	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	9.84	6.64	3.20	2.75	2.29	1.37	1.49	0.23	0.46
Anulus Pulposus Cell, donor2	11463-119B5	3.92	2.69	2.20	1.71	0.73	1.22	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.74	1.80	0.45	0.90	0.90	0.90	1.35	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.25	0.00	1.30	0.43	1.30	0.43	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	0.00	0.00	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.17	2.69	1.20	0.60	0.30	0.90	1.79	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	2.53	0.00	2.53	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	1.32	0.66	0.00	0.66	0.66	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	1.62	1.30	0.32	0.97	0.32	1.30	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	4.37	1.94	0.00	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.97	2.97	1.19	0.59	0.00	0.59	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.91	1.88	1.13	2.64	0.75	0.00	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	3.63	1.45	1.45	0.73	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	3.76	0.00	0.00	2.51	0.00	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.57	2.14	1.32	1.15	0.66	1.15	0.66	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	2.73	0.00	1.36	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.58	1.21	1.51	0.75	0.60	0.45	0.60	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	2.14	0.54	0.00	0.54	0.54	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	5.67	0.76	0.38	0.76	0.57	0.94	0.19	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.48	2.14	0.80	0.53	1.34	0.27	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	0.98	1.95	0.98	0.98	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.13	1.66	1.16	0.83	0.83	0.33	0.17	0.00	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	1.20	1.20	2.40	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00	0.00	0.00	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.09	2.57	1.20	0.86	0.86	0.69	0.69	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	4.85	0.97	0.97	0.97	1.46	0.00	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.97	1.52	1.52	1.14	0.76	0.38	0.76	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	1.21	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	2.28	1.14	0.57	0.57	0.57	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.27	1.71	1.50	0.64	0.43	0.64	0.64	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.68	2.84	1.29	0.52	1.55	0.77	0.26	0.00	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	9.38	1.88	0.47	0.47	0.47	0.00	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.40	1.61	0.64	0.96	1.29	0.32	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	3.57	0.00	1.43	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	0.58	0.00	0.58	0.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.94	2.41	2.71	1.81	1.51	0.60	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	1.19	1.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	2.03	1.53	0.51	0.51	0.00	1.02	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.42	2.29	1.27	2.04	0.00	0.51	0.51	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	0.64	1.91	0.00	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	1.29	1.29	1.29	0.86	0.00	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.87	1.91	1.06	1.06	0.64	0.42	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	0.87	0.29	0.00	0.87	0.00	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	0.00	0.94	0.00	1.89	0.00	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.12	2.37	0.51	0.68	0.68	0.51	1.19	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	6.34	2.11	2.11	0.00	4.23	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.36	2.57	0.43	0.64	0.64	0.21	0.43	0.43	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	1.80	1.20	0.00	0.60	0.00	1.80	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	3.64	0.73	0.00	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	2.99	0.69	0.69	0.23	0.46	0.46	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	0.00	5.10	0.00	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.39	3.81	1.02	0.25	0.51	1.02	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.81	1.03	0.83	0.83	0.83	0.21	0.83	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	2.14	0.92	0.61	0.92	0.00	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	1.43	0.00	0.48	0.96	0.00	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	6.65	0.89	1.33	0.22	0.89	0.89	0.67	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	3.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	2.22	0.00	1.11	0.55	1.11	1.66	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	3.18	1.85	0.26	1.59	0.26	0.53	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.72	1.09	0.73	0.36	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	30.83	6.63	5.16	3.44	2.09	2.58	2.09	0.00	1.35
Astrocyte - cerebellum, donor2	11580-120F5	8.22	1.88	1.03	0.68	0.17	0.68	1.03	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	3.36	0.63	0.63	0.84	0.84	0.63	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	55.43	20.92	13.94	7.67	14.99	3.83	2.44	0.35	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	63.58	12.29	11.49	7.28	8.57	5.18	3.40	0.32	2.91
Astrocyte - cerebral cortex, donor3	11392-118C6	54.00	15.51	9.70	12.23	10.89	5.52	1.64	0.30	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	124.20	31.88	16.17	26.03	12.39	14.11	10.21	5.16	2.06
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	145.58	31.82	18.17	23.18	11.90	12.03	10.40	5.89	2.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	156.81	31.98	17.75	22.30	16.16	12.97	10.36	4.78	3.19
Basophils, donor1	12241-129G9	10.20	3.66	4.18	2.88	1.31	0.52	1.05	1.31	0.78
Basophils, donor2	12242-129H1	20.57	18.40	14.43	9.74	9.02	1.80	1.44	3.97	3.61
Basophils, donor3	12243-129H2	11.32	5.44	4.70	3.82	1.62	1.03	0.44	1.32	1.32
Bronchial Epithelial Cell, donor1	11511-119G8	2.16	1.51	0.00	0.65	0.00	0.22	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.91	0.00	0.00	0.00	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	7.53	1.26	1.26	0.00	1.88	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.78	0.83	0.21	0.42	0.00	0.00	0.21	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	2.76	0.69	0.46	0.23	0.00	0.23	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	5.22	4.86	0.90	2.34	1.08	1.62	3.24	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	95.33	56.78	25.76	20.10	13.60	9.38	7.21	1.65	2.78
Burkitt's lymphoma cell line:RAJI	10476-106I8	125.77	59.62	34.00	23.99	17.93	7.69	3.96	3.03	4.89
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	32.94	13.11	8.63	7.67	7.99	1.60	1.28	4.80	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	31.03	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	8.45	3.94	2.82	3.94	1.69	0.00	0.56	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	9.09	7.42	4.64	6.50	3.90	1.67	0.56	1.11	1.67
CD14+ Monocytes, donor3	11381-118B4	9.00	5.93	4.17	2.41	2.20	1.10	1.76	2.85	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	3.96	7.93	2.83	2.26	1.98	1.70	1.70	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	9.86	7.58	4.93	6.44	0.00	0.38	1.90	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	5.92	8.55	3.94	3.29	0.33	1.31	0.99	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	6.22	2.17	2.75	1.88	2.31	0.43	0.29	0.00	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	3.32	1.21	3.92	1.81	2.72	0.00	0.00	0.60	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	3.08	1.90	1.66	1.18	2.84	0.00	0.47	0.00	2.13
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.03	1.51	4.02	1.51	2.34	0.17	0.17	0.33	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.93	3.04	2.21	1.93	2.48	0.00	0.00	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.20	3.47	3.22	1.49	3.22	0.25	0.25	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.29	2.55	3.72	1.37	2.35	0.20	0.39	0.20	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.63	2.49	2.85	2.31	3.38	0.18	0.00	0.36	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.01	3.92	5.01	3.26	5.22	0.00	0.22	0.65	1.74
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.02	4.68	5.62	2.11	3.75	0.23	0.23	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	2.11	5.28	2.11	8.98	0.00	0.00	1.06	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	8.87	9.98	5.55	1.11	5.55	1.11	0.00	0.00	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.76	3.12	2.83	1.78	2.53	0.00	0.00	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.99	2.99	2.20	0.40	2.20	0.20	0.20	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	7.08	3.54	2.71	1.25	2.08	0.21	0.21	0.62	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.86	1.83	4.35	1.60	2.06	1.14	0.23	0.46	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.01	2.71	4.98	2.04	2.71	0.00	0.45	0.90	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.55	2.18	3.49	1.31	2.62	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.30	3.77	4.30	1.61	4.30	0.27	0.00	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.31	2.97	4.36	2.44	3.14	0.52	0.17	0.35	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	3.37	2.10	2.52	1.68	2.95	0.00	0.00	0.42	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.27	2.94	3.86	1.65	3.86	0.37	0.00	0.37	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.34	3.87	4.58	1.41	2.82	0.35	0.35	0.00	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.39	4.39	4.39	3.95	2.63	0.44	0.44	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.75	3.66	3.84	2.44	2.27	0.70	0.00	0.87	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.83	4.46	4.46	5.58	4.46	0.00	0.00	0.00	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.33	3.23	6.25	1.94	4.96	0.65	0.65	0.43	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.42	2.46	3.28	1.64	2.46	0.41	0.00	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.50	3.71	6.72	3.01	3.48	0.23	0.23	0.00	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.35	3.25	4.64	3.25	4.18	0.00	0.00	1.16	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	6.10	5.23	2.62	1.53	1.31	0.00	0.00	0.87	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	6.70	4.85	2.77	0.69	1.15	0.00	0.00	1.39	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	7.36	5.63	2.82	1.08	0.87	0.43	0.00	0.87	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	7.32	9.81	6.85	2.65	4.05	0.16	1.56	1.56	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	8.56	9.08	5.76	2.45	2.10	0.70	0.52	2.45	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	14.27	10.70	4.24	4.01	1.34	0.89	2.68	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	4.59	3.57	2.30	1.79	0.26	0.51	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	4.17	5.71	2.42	0.88	0.22	0.22	0.44	1.32	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	5.90	4.00	1.68	1.68	0.21	0.21	0.63	0.63	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	24.39	10.16	12.19	6.10	0.00	0.00	4.06	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	21.70	5.42	6.10	5.42	0.68	2.03	2.03	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	18.64	26.93	19.68	13.46	6.21	2.07	1.04	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	26.65	23.45	16.52	16.52	8.53	0.53	2.67	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.09	28.41	18.76	13.94	12.33	2.14	2.68	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	14.74	16.85	8.42	3.51	2.11	0.00	1.40	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.96	19.61	14.12	14.90	3.92	0.78	0.78	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	31.64	29.00	9.23	13.18	5.27	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	9.04	14.79	11.51	7.40	10.68	1.64	0.00	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	8.71	11.61	10.16	6.53	7.98	0.00	0.73	1.45	5.80
CD19+ B Cells, donor3	11705-123B4	11.11	10.60	7.57	9.09	9.59	0.50	0.00	1.51	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	560.83	38.79	17.37	14.55	6.46	20.61	26.26	2.02	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	314.40	28.36	10.39	9.19	7.19	11.19	16.78	0.40	2.00
CD34+ Progenitors, donor1	11545-120B6	6.02	3.01	6.02	3.01	2.01	0.00	0.00	1.00	3.01
CD34+ Progenitors, donor2	11625-122B5	11.80	6.18	7.30	5.06	3.93	1.12	1.69	3.37	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.48	19.54	11.27	10.52	5.26	4.13	1.88	1.88	3.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	52.99	22.32	14.21	12.40	6.76	2.03	2.93	2.93	2.25
CD4+ T Cells, donor1	11225-116C1	26.07	25.71	16.42	17.85	8.93	3.57	2.86	2.14	3.57
CD4+ T Cells, donor2	11306-117C1	17.15	17.15	16.53	9.19	12.86	3.06	3.06	0.61	3.67
CD4+ T Cells, donor3	11382-118B5	21.35	22.26	15.86	11.28	8.54	1.83	1.22	1.22	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	18.89	27.31	15.57	8.93	5.36	1.28	1.02	2.04	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.73	29.65	11.90	8.98	4.94	2.70	2.47	2.47	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	18.68	27.88	14.37	5.75	5.17	1.15	1.44	3.16	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	12.80	16.59	7.11	5.22	4.74	1.42	1.90	0.95	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.83	16.86	9.13	8.43	4.92	2.81	1.40	0.00	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	23.07	6.59	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	48.27	28.33	20.67	10.69	10.84	2.89	1.59	3.03	3.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	37.62	25.93	19.49	8.98	6.27	1.36	1.36	1.36	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	37.24	23.05	18.86	9.19	9.51	1.13	0.48	1.61	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.90	15.24	8.07	5.83	5.83	0.00	1.34	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	17.82	19.22	13.98	5.94	4.54	1.40	1.05	1.40	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	21.12	34.32	16.28	10.12	5.28	0.88	2.20	3.52	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	45.12	32.04	21.50	6.32	10.12	0.42	2.95	2.53	5.90
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.78	25.56	18.28	11.22	11.22	1.04	1.87	2.29	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.72	17.04	19.05	6.35	9.02	0.67	0.33	1.67	3.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	13.32	17.95	8.70	5.71	4.08	1.09	2.99	0.27	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	9.11	19.83	9.65	9.65	3.22	2.68	1.61	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	12.55	19.73	14.35	12.55	7.17	0.00	0.00	0.00	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	72.87	36.90	29.48	14.46	16.50	3.34	1.30	1.67	7.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	52.85	24.69	22.31	10.40	9.96	2.17	0.87	2.38	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	46.65	26.06	17.23	9.46	6.51	1.68	0.21	2.73	2.52
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	13.65	15.67	6.57	8.60	2.53	0.51	2.53	0.51	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	15.60	22.96	13.00	6.50	7.37	1.73	1.73	0.87	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	27.46	36.61	17.00	18.30	11.77	0.44	3.05	2.18	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	30.68	27.71	13.86	6.93	5.44	1.98	3.46	1.98	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	25.85	11.08	8.31	2.77	3.69	1.85	1.85	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	27.92	16.75	8.37	4.19	4.19	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	37.94	42.92	21.32	18.55	6.92	4.71	5.26	2.22	2.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	58.16	57.67	24.78	22.09	6.87	4.42	10.80	4.17	2.70
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	38.50	32.34	15.40	13.86	1.54	0.00	1.54	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	29.72	31.87	18.98	18.98	7.88	2.86	3.22	1.79	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	30.47	19.39	16.62	4.15	2.77	1.38	4.15	1.38
CD8+ T Cells, donor1	11226-116C2	29.79	19.32	14.08	10.48	7.53	4.58	5.24	2.29	3.27
CD8+ T Cells, donor2	11307-117C2	24.78	9.76	9.76	11.26	11.64	3.00	1.88	2.25	3.38
CD8+ T Cells, donor3	11383-118B6	27.27	18.18	9.09	10.35	7.57	4.04	3.53	3.03	3.03
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	46.34	14.22	7.34	3.90	4.82	0.00	0.00	0.69	3.67
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	46.97	14.14	9.35	3.83	6.23	0.48	0.96	0.48	2.64
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	48.15	13.13	13.41	3.56	9.30	0.27	1.37	0.82	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	48.63	15.01	10.21	7.51	7.51	1.20	0.90	0.90	2.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	32.40	8.64	6.48	2.40	6.24	1.20	0.24	0.00	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	42.75	10.23	7.28	3.64	5.91	0.68	1.14	0.68	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	58.88	11.30	6.74	3.04	3.04	0.65	0.87	1.09	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	51.59	10.00	8.69	2.37	3.42	0.79	0.26	0.79	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	52.06	11.02	6.80	1.64	5.86	0.47	1.17	0.47	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	66.71	15.70	9.36	2.42	6.34	0.60	0.60	1.51	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	67.98	11.04	8.13	1.45	9.30	0.87	0.58	0.29	2.91
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	57.82	15.45	9.59	3.20	3.46	0.53	0.00	0.53	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	45.96	8.76	5.25	4.82	4.38	0.44	0.88	1.75	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	49.64	11.84	6.38	2.73	3.19	1.37	0.46	1.37	4.55
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	46.24	15.66	5.97	0.75	6.71	0.75	1.49	0.75	2.98
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	37.10	11.16	5.04	2.52	4.32	0.36	0.36	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	40.28	12.37	9.78	3.74	4.60	2.59	1.73	0.86	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	31.82	9.90	4.24	2.59	4.71	1.18	0.94	0.47	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	45.63	13.63	4.12	4.12	4.75	1.90	1.90	1.27	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	52.29	16.30	6.77	3.38	5.23	0.31	0.31	0.92	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	56.74	8.66	8.01	2.24	7.05	2.24	0.32	0.32	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	58.13	16.45	8.41	3.44	4.97	2.29	1.53	0.76	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	53.99	15.37	4.34	2.76	5.52	0.79	0.79	2.36	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	43.12	15.13	6.81	2.27	5.29	1.51	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	39.34	18.47	10.44	8.03	11.24	0.80	0.00	0.80	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	39.87	25.18	11.89	8.39	13.99	0.70	0.00	2.10	6.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	26.05	10.02	3.01	8.01	2.00	0.00	2.00	4.01
Cardiac Myocyte, donor1	11525-119I4	1.83	1.83	1.83	0.00	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	17.79	1.98	3.46	1.98	0.00	0.99	0.49	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	19.15	5.68	3.26	5.05	3.05	0.84	1.26	0.00	0.74
Chondrocyte - de diff, donor1	11261-116G1	51.31	9.01	7.28	4.85	5.55	2.08	2.08	1.04	2.08
Chondrocyte - de diff, donor2	11338-117F6	3.91	1.78	0.00	0.71	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	9.90	1.93	1.82	1.37	1.25	0.91	0.80	0.80	0.34
Chondrocyte - re diff, donor2	11339-117F7	23.28	5.37	13.43	3.58	0.00	1.79	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	4.85	4.45	2.02	1.62	2.43	0.81	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	49.00	14.80	13.08	7.80	9.64	2.87	2.87	0.34	2.18
Ciliary Epithelial Cells, donor2	11323-117D9	25.65	6.20	6.41	3.85	3.85	1.07	1.07	0.43	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	25.66	9.20	7.26	6.11	4.16	2.04	1.50	0.09	1.59
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	11.19	5.50	3.76	4.03	3.12	2.20	2.38	0.28	1.01
Corneal Epithelial Cells, donor1	11526-119I5	1.98	1.76	0.22	0.44	0.00	0.44	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	0.00	5.69	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.11	1.79	1.02	0.26	0.51	0.51	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	6.93	3.63	0.99	0.99	0.17	1.16	1.16	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.10	2.52	0.95	1.58	0.00	0.63	1.26	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	0.00	3.45	3.45	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.08	2.27	1.08	0.76	0.11	0.22	0.65	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.52	7.86	2.39	1.02	1.71	2.39	0.68	0.34	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	8.49	9.79	1.31	4.57	1.31	1.96	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	11.61	5.81	2.42	1.94	0.48	5.32	2.42	0.00	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	7.00	1.50	0.50	0.67	0.50	0.50	1.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	3.52	1.17	1.17	1.17	0.59	0.59	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.33	1.98	1.98	2.55	0.00	0.85	0.57	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	2.75	1.57	1.97	0.39	0.00	0.00	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	6.69	2.33	0.87	1.16	0.29	0.87	0.00	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	21.41	3.29	3.06	1.88	0.47	2.35	0.71	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	6.84	2.28	0.88	1.40	0.35	1.05	1.05	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.54	5.76	2.44	2.44	1.33	0.44	1.33	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.61	7.61	2.74	5.17	1.83	0.61	1.22	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.58	7.33	3.38	5.64	2.26	1.41	3.10	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.40	4.16	1.78	1.19	0.89	0.30	2.08	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	3.12	0.52	1.04	1.04	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	3.12	0.99	1.42	0.99	0.14	0.85	0.28	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	38.41	9.60	4.40	5.20	2.80	1.60	2.40	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	4.19	1.05	0.00	1.05	0.52	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	54.54	21.49	11.06	8.70	5.59	3.35	2.11	0.00	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.63	15.64	4.78	4.78	4.13	1.96	1.96	0.43	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	45.43	13.19	4.03	5.13	3.54	3.42	2.32	0.12	1.71
Endothelial Cells - Vein, donor1	11267-116G7	2.28	3.41	0.00	0.00	1.14	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	0.70	0.00	0.00	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	9.42	2.83	1.26	1.41	0.79	0.63	0.63	0.00	0.16
Eosinophils, donor1	12244-129H3	30.49	15.25	45.74	15.25	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	41.26	9.90	9.90	3.30	3.30	0.00	0.00	3.30	0.00
Eosinophils, donor3	12246-129H5	32.10	7.13	7.13	7.13	0.00	0.00	3.57	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.95	0.73	0.00	0.73	0.24	0.49	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.12	5.75	3.28	2.05	4.52	0.41	0.00	0.41	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	2.96	0.77	0.33	0.22	0.22	0.11	0.22	0.00	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.97	1.84	3.03	0.76	2.17	0.43	0.43	0.00	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	40.75	8.73	7.76	2.91	4.97	1.09	1.46	0.12	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.87	5.73	2.32	2.46	1.23	0.27	0.55	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.76	3.38	2.32	1.48	2.53	0.00	0.32	0.32	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.08	7.90	4.22	2.63	4.22	0.53	0.00	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	36.54	5.98	5.65	2.33	2.99	2.33	1.33	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	7.26	1.81	1.36	2.72	2.27	0.45	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	0.76	0.00	0.76	0.76	0.76	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	11.51	1.42	1.42	0.47	1.42	0.32	0.00	0.16	0.79
Fibroblast - Cardiac, donor4	11452-119A3	31.83	7.58	5.46	6.06	1.82	1.21	3.03	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	26.65	6.09	3.30	3.05	2.79	1.65	0.63	0.00	0.51
Fibroblast - Cardiac, donor6	11460-119B2	28.80	5.91	3.94	4.09	1.97	1.82	2.27	0.00	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.06	2.95	1.88	1.47	1.61	0.80	0.67	0.00	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	1.73	2.59	2.59	4.31	0.43	0.43	0.00	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	11.72	5.86	2.93	2.93	4.39	2.93	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	13.15	2.08	1.38	1.15	0.92	0.69	0.69	0.46	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	5.09	4.41	3.90	1.70	1.53	1.19	1.36	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	12.68	1.17	0.70	0.94	1.41	0.47	1.64	0.47	0.70
Fibroblast - Dermal, donor2	11346-117G5	10.85	1.42	0.00	0.00	0.00	0.47	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.76	2.78	1.09	1.21	1.45	0.85	0.48	0.36	0.12
Fibroblast - Dermal, donor4	11450-119A1	52.23	11.19	5.77	4.75	1.92	4.63	3.73	0.45	0.34
Fibroblast - Dermal, donor5	11454-119A5	59.49	8.55	4.36	4.54	3.49	2.79	2.79	0.17	0.87
Fibroblast - Dermal, donor6	11458-119A9	74.23	11.53	4.71	4.87	4.22	4.87	3.25	0.32	1.14
Fibroblast - Gingival, donor1	11237-116D4	30.40	6.87	2.92	1.87	1.87	1.87	2.92	1.46	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.79	4.98	3.67	1.83	3.14	1.31	0.26	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	45.33	9.09	4.88	2.77	1.71	3.82	3.43	0.40	0.53
Fibroblast - Gingival, donor3	11394-118C8	14.50	5.51	2.03	2.51	1.16	2.13	1.84	1.16	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	5.19	3.12	1.04	0.00	1.04	2.08	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	9.87	1.06	1.41	0.70	0.88	0.35	0.18	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	47.86	5.61	5.77	2.65	4.99	2.81	1.71	0.62	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.62	5.68	2.70	1.35	4.06	0.95	1.76	0.41	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.64	2.82	2.12	1.06	1.76	1.41	0.71	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	32.76	6.58	5.12	2.63	3.22	1.17	1.61	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	51.41	8.32	5.59	2.18	5.73	1.36	1.50	0.27	2.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	67.46	8.01	7.24	2.85	6.91	1.97	1.32	0.66	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.75	1.61	0.88	1.61	0.44	0.29	0.73	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	2.72	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	10.45	7.46	5.97	5.97	4.48	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	21.53	4.64	1.27	2.53	2.11	2.11	1.90	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	3.33	0.00	0.00	0.00	0.83	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	2.80	0.00	1.40	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	0.00	0.00	0.00	0.00	0.00	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	33.70	1.22	2.44	3.65	0.41	0.81	1.22	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	81.47	15.13	6.40	2.91	5.04	4.66	5.63	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	89.64	11.68	6.83	6.67	3.79	7.58	4.70	0.15	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	93.33	11.32	5.51	8.57	2.14	3.67	5.20	1.22	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	32.82	6.49	3.43	3.05	3.82	2.67	0.76	1.14	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.09	2.70	2.43	2.16	2.16	1.08	0.27	0.54	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.55	1.74	2.09	0.81	0.70	0.70	0.35	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	48.19	6.30	5.20	2.98	4.20	1.22	1.66	0.33	0.66
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.12	2.44	1.83	1.22	0.41	0.81	1.42	0.41	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	1.34	2.00	0.00	0.67	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.47	1.98	1.19	1.98	1.19	0.79	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	45.05	7.34	6.35	6.15	5.75	1.59	1.39	0.60	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.88	2.13	1.95	1.24	1.07	0.89	0.89	0.89	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.77	5.91	3.35	2.76	1.77	0.59	0.99	0.79	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	32.19	3.91	3.31	2.11	2.41	1.50	0.60	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	39.08	6.91	6.15	3.89	2.81	1.51	2.48	0.65	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.40	5.06	2.78	3.29	0.76	0.00	0.76	0.25	0.76
Fibroblast - skin normal, donor1	11553-120C5	12.63	3.77	1.48	1.15	0.66	0.49	0.16	0.16	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	45.11	7.42	5.61	5.81	4.01	0.80	2.01	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	56.86	7.43	5.73	4.72	4.52	2.41	2.41	0.30	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.41	8.16	7.56	6.95	6.95	0.60	0.60	0.30	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.10	3.73	3.07	1.41	1.82	0.41	0.58	0.17	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.68	7.35	5.47	2.22	2.05	0.68	0.68	0.51	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	23.32	1.97	3.61	1.31	1.97	1.64	0.99	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	61.89	8.95	4.37	2.66	3.52	1.81	1.81	0.85	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	43.52	5.74	3.20	2.70	3.20	2.02	1.69	0.00	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.09	2.04	1.25	1.10	1.25	1.25	1.10	0.31	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1950.06	110.80	66.48	66.48	155.12	110.80	88.64	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.10	4.36	0.87	0.00	0.00	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.01	2.25	0.35	0.52	0.17	1.04	0.69	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	20.82	2.60	1.56	1.04	0.52	2.60	1.82	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	14.56	1.79	0.77	0.51	0.00	1.02	1.53	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	27.56	6.12	3.06	0.77	0.77	0.77	2.30	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	33.82	8.29	6.38	1.28	5.10	1.91	0.64	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	132.36	23.96	9.13	5.42	6.56	10.55	6.56	0.29	3.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	30.88	33.64	18.20	22.06	12.13	7.17	2.76	0.55	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.74	14.84	17.12	13.01	12.79	2.28	1.83	0.46	5.94
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	83.41	18.82	9.71	7.13	7.13	6.14	2.77	0.59	3.57
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	31.19	33.83	15.86	15.86	9.78	6.08	2.64	0.00	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	26.09	18.26	10.44	10.76	9.78	3.26	3.59	1.30	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	139.74	14.15	12.38	7.08	6.63	9.73	5.31	0.44	5.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	53.56	15.97	7.07	5.65	6.08	5.94	3.11	0.42	2.40
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.44	13.67	8.87	4.93	9.48	3.82	1.72	0.37	3.32
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	48.35	12.63	8.33	4.03	6.98	2.69	2.15	0.00	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.96	8.92	4.96	3.59	4.83	4.46	2.35	0.37	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	48.59	7.34	4.43	3.32	2.91	5.40	2.21	0.14	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	46.56	7.12	3.05	5.29	3.86	3.86	2.85	0.20	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	18.71	7.76	7.99	6.16	4.34	1.60	0.91	0.23	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	24.79	7.47	2.99	2.49	3.24	2.62	2.24	0.25	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.95	6.99	2.40	3.06	2.84	4.59	3.93	0.87	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.64	10.34	7.68	3.25	6.21	2.66	1.48	0.00	2.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.25	13.19	9.06	5.56	6.84	1.59	1.43	0.16	4.45
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.55	6.48	3.35	5.59	2.68	2.01	1.56	0.22	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	27.02	14.32	8.07	8.07	13.11	1.81	1.01	0.20	2.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	38.68	16.96	12.38	8.48	8.99	2.37	1.02	0.34	5.26
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	45.13	15.25	12.68	7.18	10.37	2.84	2.57	0.18	3.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	18.73	15.71	12.69	7.08	9.37	2.50	2.50	0.10	2.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.32	20.32	12.98	10.59	6.49	1.71	1.37	0.34	2.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.81	13.94	8.63	6.97	8.74	3.10	1.55	0.00	2.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.19	15.22	11.98	8.74	9.73	2.58	2.08	0.17	3.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.46	15.93	11.43	7.55	7.15	2.65	1.23	0.20	2.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.85	16.71	8.25	8.87	8.25	1.44	1.65	0.00	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	16.37	12.22	10.38	6.57	6.00	2.19	2.54	0.00	2.77
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	19.01	10.84	9.01	6.67	5.84	2.33	1.00	0.17	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.23	7.94	6.17	8.82	5.73	2.20	1.10	0.00	2.65
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	13.90	13.41	7.01	6.15	6.15	1.72	1.60	0.61	2.58
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.15	11.99	8.27	6.00	6.65	2.92	2.11	0.00	2.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	8.66	7.70	6.09	5.45	6.09	1.92	1.60	0.64	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	14.21	11.56	6.73	5.31	5.50	2.37	1.99	0.19	1.80
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	16.92	11.39	6.17	6.33	3.95	1.27	0.79	0.16	1.58
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	18.25	11.86	7.60	3.34	6.39	2.74	0.61	0.00	3.34
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.07	10.35	7.11	6.38	4.50	2.30	1.78	0.10	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.10	9.66	5.27	4.61	3.73	2.42	0.22	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	13.47	7.01	5.89	4.21	4.21	1.96	2.24	0.28	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.05	6.39	1.85	4.07	2.59	1.48	1.39	0.19	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.85	6.42	4.55	5.08	3.21	1.87	1.34	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	26.47	8.26	3.37	3.52	3.52	1.53	0.92	0.15	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.26	6.35	3.11	2.07	2.59	1.17	0.65	0.13	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.39	5.15	2.71	3.25	1.63	1.90	1.63	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.38	6.27	4.61	3.50	4.98	1.11	0.37	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	12.28	3.95	4.61	3.07	6.58	0.22	0.22	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	10.91	11.90	10.91	4.96	3.97	0.99	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	14.51	3.56	3.56	2.11	3.96	0.26	0.66	0.13	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.12	4.64	2.42	3.03	1.01	2.02	0.61	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	14.74	11.69	8.64	4.83	4.83	2.29	3.30	0.00	3.05
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	154.87	24.88	10.15	10.35	9.16	7.37	5.97	0.00	4.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.61	10.17	4.01	3.54	4.31	7.09	4.93	0.31	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	98.40	14.32	8.39	6.34	9.82	9.41	3.68	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	51.63	8.14	8.45	5.01	7.82	0.63	0.63	0.31	3.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	48.88	7.06	5.93	3.96	5.09	1.41	0.57	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	74.25	14.76	9.69	7.84	9.69	3.69	2.31	0.00	3.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	12.37	9.90	4.95	4.95	4.95	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	63.44	15.09	11.60	7.74	8.12	1.93	3.09	0.00	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	59.37	14.44	12.84	1.60	28.88	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	13.91	1.74	6.96	6.96	3.48	1.74	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	65.75	17.90	14.00	6.18	9.11	2.93	0.65	0.00	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	65.48	17.71	11.12	8.24	10.71	2.47	0.82	0.41	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	19.99	13.33	3.33	23.33	3.33	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.70	21.53	13.14	8.39	9.79	2.24	1.68	0.00	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	47.07	13.73	9.48	11.77	11.44	1.96	2.29	0.00	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.94	17.62	18.45	5.87	13.42	0.84	0.84	0.84	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	48.98	21.63	12.72	6.36	12.72	1.59	1.27	0.32	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.08	19.02	8.83	7.47	8.49	2.04	0.34	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	33.41	8.35	6.26	0.00	10.44	2.09	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.36	23.48	13.74	6.87	5.15	2.86	0.57	0.00	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	20.13	11.84	8.29	5.62	5.03	1.18	1.18	0.00	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	20.33	8.47	5.08	20.33	1.69	0.00	0.00	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.88	16.57	11.18	7.46	14.91	1.24	0.83	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	47.41	18.41	14.50	11.05	18.87	1.38	0.46	0.23	5.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	26.34	10.54	15.81	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.22	12.69	12.69	10.76	16.15	1.54	1.54	0.38	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	24.45	15.97	6.52	6.52	13.36	1.30	0.98	0.33	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.73	9.36	5.35	6.69	4.01	0.67	0.67	0.00	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	22.73	19.26	8.48	8.48	15.03	2.31	0.77	0.00	6.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	35.60	13.35	8.22	6.16	11.64	2.05	1.37	1.37	3.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	9.94	14.91	9.94	7.45	7.45	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	22.18	15.10	6.13	11.80	10.38	0.00	2.36	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.31	13.88	16.29	6.64	11.47	1.21	0.60	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	14.75	12.72	8.14	9.16	1.02	1.02	0.51	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	24.33	17.95	9.57	8.38	15.95	2.79	1.99	0.00	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	23.68	13.81	10.36	12.33	2.96	1.48	0.00	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	22.43	9.44	3.54	8.26	4.72	3.54	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	18.09	16.92	7.58	2.92	9.92	0.00	0.00	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	13.61	14.04	7.02	9.22	7.46	2.63	0.00	1.32	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	12.72	4.24	2.54	6.78	1.70	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	11.34	7.16	4.18	7.16	0.00	0.00	0.00	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	13.10	12.13	10.19	5.34	12.62	0.97	0.49	0.49	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	2.28	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	2.08	0.83	1.25	0.42	0.00	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1.12	0.00	2.25	1.12	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	4.76	3.17	1.27	0.95	1.27	0.63	0.95	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.51	4.18	0.84	0.00	0.00	0.42	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	76.12	14.27	9.17	6.03	5.45	3.83	3.37	1.04	1.74
Hep-2 cells mock treated, biol_rep2	11899-125E9	73.60	18.74	9.45	4.90	4.39	4.56	3.04	0.68	2.19
Hep-2 cells mock treated, biol_rep3	11900-125F1	75.08	15.70	10.47	7.96	7.96	3.87	3.19	0.91	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	72.58	16.18	9.62	3.72	5.68	3.17	3.06	0.66	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	71.14	16.98	8.81	6.02	5.37	4.08	2.58	0.43	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	75.56	20.88	8.83	5.17	5.17	4.95	3.44	0.22	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.88	11.96	8.97	5.73	7.47	4.73	1.49	0.62	1.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	60.21	16.64	8.75	2.74	5.32	3.09	1.54	0.51	3.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	58.95	15.70	8.33	3.52	4.16	2.24	1.60	0.64	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.24	3.36	1.12	0.00	1.12	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.87	0.00	0.87	0.00	0.00	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	1.76	1.06	0.35	0.71	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	2.91	0.00	1.45	0.00	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	37.07	8.22	6.64	3.67	5.59	0.87	0.87	0.70	1.05
Hepatocyte, donor1	11523-119I2	9.68	3.63	6.05	4.84	3.63	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	6.46	2.15	1.08	2.15	4.31	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	14.72	5.52	1.23	3.07	2.45	1.84	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	114.22	23.50	11.10	7.18	11.75	7.18	0.00	0.65	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	16.60	5.94	3.32	1.92	2.80	1.57	2.62	0.17	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	31.97	9.19	3.57	4.67	1.92	1.37	2.06	0.27	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38	1.38	0.00	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	2.50	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	1.62	1.62	1.62	0.00	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	1.67	0.00	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	0.00	3.63	3.63	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	2.65	0.00	0.00	0.00	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	0.00	0.00	1.11	0.00	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	0.00	0.00	0.63	0.63	2.52	1.89	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	0.00	0.00	1.55	0.00	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	7.75	3.23	0.00	0.00	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	0.00	0.00	3.22	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	2.44	0.00	0.81	0.00	0.81	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.72	0.42	0.42	0.42	0.84	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	14.47	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.97	1.89	0.00	0.00	0.00	0.47	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	3.63	0.00	0.00	0.00	1.81	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	0.00	0.00	1.08	0.00	1.08	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	0.00	0.00	0.00	0.00	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	0.00	0.00	0.00	1.28	1.28	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	0.71	0.71	0.00	0.71	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.35	2.47	0.62	0.31	0.31	1.85	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	1.76	0.00	0.00	0.00	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	3.14	0.00	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.95	1.39	0.70	0.00	0.00	2.78	1.39	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	0.87	0.87	0.00	0.00	0.87	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	0.00	1.07	1.07	0.00	0.00	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	1.39	0.00	0.00	1.39	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	2.85	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	0.92	0.00	0.00	0.00	2.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	1.06	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.18	3.02	2.28	1.31	1.22	1.14	1.31	0.16	0.33
Keratinocyte - epidermal, donor2	11349-117G8	1.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	20.54	6.91	2.75	2.93	1.89	2.56	2.46	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	16.91	11.69	4.99	4.65	2.50	4.54	4.77	0.68	0.11
Keratocytes, donor1	11527-119I6	8.94	3.78	1.38	1.38	0.00	1.38	1.38	0.00	0.00
Keratocytes, donor2	11607-120I5	4.69	1.17	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	4.74	3.75	3.36	2.96	1.58	1.19	0.59	0.99	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	6.59	0.00	4.40	4.40	8.79	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	9.71	6.47	0.00	2.16	3.24	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	30.91	16.38	9.57	10.50	5.77	4.15	3.92	0.58	1.27
Lens Epithelial Cells, donor3	11690-122I7	17.26	8.07	5.15	7.27	4.34	1.41	0.61	0.30	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.57	2.49	0.95	2.02	2.02	0.71	1.42	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.42	2.51	1.40	1.12	0.84	0.28	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.75	6.61	4.72	3.46	2.83	0.79	0.47	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.76	2.69	0.54	0.54	0.54	0.00	1.61	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.78	1.26	0.32	0.63	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.45	1.94	0.86	0.32	1.19	0.32	0.11	0.00	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	8.62	4.92	2.46	0.41	1.23	0.41	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	1.01	0.76	0.76	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.22	2.67	1.27	1.55	0.84	0.28	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.31	3.16	2.37	0.79	0.40	0.79	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.27	2.71	2.33	0.00	1.74	0.19	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	0.93	0.74	0.37	0.56	0.37	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.27	3.48	1.05	1.74	2.09	0.70	1.05	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.05	2.15	0.72	0.72	0.95	0.72	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.75	1.10	0.82	1.51	0.82	0.14	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.55	3.70	3.08	1.23	0.62	0.62	1.85	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.56	0.62	0.31	0.31	0.31	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.29	2.93	0.73	0.37	0.73	0.00	0.18	0.18	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.61	3.62	1.65	0.66	1.32	0.33	1.65	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.64	0.29	0.59	0.00	0.29	0.29	0.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.00	1.24	1.24	0.50	0.50	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	5.82	4.36	1.94	1.45	0.00	0.97	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.31	2.15	1.89	1.08	1.08	0.27	0.27	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.15	1.67	1.36	1.36	1.06	0.15	0.61	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	2.07	1.04	0.00	1.04	0.52	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	2.93	3.35	0.84	2.51	1.05	0.42	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.51	2.56	1.80	0.45	0.45	0.60	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	2.06	1.38	0.69	0.69	0.00	0.00	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	4.70	0.56	1.51	0.19	1.13	0.56	0.56	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.01	1.48	1.48	0.64	0.95	0.11	0.42	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.30	2.42	1.94	0.97	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	0.33	0.99	0.33	1.65	0.00	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.73	1.49	0.74	0.50	0.50	0.37	0.12	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.51	9.26	2.96	1.48	2.22	0.37	0.74	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.96	1.48	1.98	0.49	0.25	0.74	0.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.34	1.10	0.69	0.41	0.27	0.55	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.72	3.22	1.93	0.96	1.61	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.39	3.96	2.74	1.83	1.83	1.52	0.00	0.00	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.42	3.50	3.36	0.84	2.80	0.28	0.98	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.62	2.49	0.36	2.13	1.07	0.71	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.45	0.48	0.97	0.48	0.00	0.00	0.00	0.00	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.49	1.40	0.62	0.47	0.47	0.16	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.01	3.94	1.43	1.07	0.72	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	1.31	1.63	0.33	0.33	0.33	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.65	0.47	0.24	0.00	0.24	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	9.41	4.58	1.61	2.72	1.36	0.74	0.50	0.12	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.31	0.77	1.28	0.26	0.26	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.28	1.79	0.90	1.19	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	0.00	0.00	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	0.77	1.53	0.00	0.00	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.04	1.69	0.42	0.42	0.42	1.27	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	10.55	0.70	0.00	0.00	0.00	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	10.27	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	3.61	1.03	1.03	0.00	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	0.00	0.00	0.00	1.19	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.95	1.58	0.23	0.23	0.00	0.68	1.13	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.96	3.78	1.16	0.29	0.00	1.45	2.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	23.41	4.50	0.90	0.90	0.45	5.40	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	7.86	0.95	0.27	0.00	0.68	0.68	1.08	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	5.65	1.54	0.51	0.00	0.00	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.35	3.88	0.00	1.06	0.00	2.12	1.76	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	4.00	2.00	0.67	0.00	2.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.62	1.53	0.51	0.00	0.00	1.02	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.81	2.93	1.33	1.07	0.00	2.13	2.40	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.03	2.83	1.13	0.76	0.00	3.02	2.65	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	3.07	0.61	0.00	0.00	0.00	1.23	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	11.42	2.45	0.82	1.63	0.00	0.82	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.08	1.04	1.04	1.46	0.21	2.08	1.87	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.29	3.64	3.08	0.84	0.28	2.52	1.40	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	0.00	0.00	0.00	0.00	5.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	19.74	3.19	1.45	0.87	0.29	2.32	1.45	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.96	2.39	1.79	0.90	0.00	2.39	1.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	18.81	2.77	0.55	1.11	0.00	2.77	2.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.60	0.71	1.06	0.71	0.35	2.47	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	10.69	1.84	1.11	0.37	0.37	0.37	2.58	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	0.00	0.00	0.00	0.00	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.14	0.77	1.15	0.00	0.38	1.15	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.62	0.57	1.13	0.57	0.57	1.13	1.13	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.03	0.82	0.00	0.82	0.00	0.82	2.46	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.59	2.26	0.45	0.00	0.00	1.81	0.90	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	2.87	0.72	0.00	0.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	2.24	0.00	0.00	0.75	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.55	2.60	1.11	0.74	0.00	2.97	1.49	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.48	0.86	0.43	0.43	0.86	2.15	1.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7.71	2.57	0.00	0.86	0.00	0.86	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	3.00	0.67	1.00	0.00	3.33	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.22	0.60	1.21	0.60	0.60	1.21	3.02	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	0.71	0.00	0.00	0.00	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	0.00	0.34	0.00	0.00	1.37	1.72	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	0.54	0.54	0.00	0.00	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	0.00	0.00	0.00	0.00	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.52	1.11	0.37	0.37	0.37	1.11	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	0.00	0.00	0.00	1.16	1.16	5.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	0.00	0.00	0.00	0.00	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	9.20	0.40	0.40	0.40	0.00	2.00	1.60	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	0.00	0.00	0.73	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.20	0.77	0.77	0.77	0.00	1.53	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.92	0.99	0.49	0.00	0.00	2.47	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	0.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.03	0.00	0.00	0.50	0.00	3.52	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.01	0.45	0.00	0.00	0.00	0.45	1.35	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	3.44	0.00	0.00	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	0.00	0.00	0.00	0.45	1.78	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	6.65	0.39	0.00	0.00	1.17	0.78	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1.98	1.32	0.00	0.00	0.00	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.26	0.00	1.04	0.52	0.52	2.59	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	11.38	1.31	0.00	0.44	0.00	2.19	2.19	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	2.24	0.00	0.00	0.56	3.91	2.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	5.74	1.32	0.44	1.32	1.32	1.77	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.64	0.77	0.00	0.39	0.00	3.47	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.09	2.53	0.00	0.00	0.00	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.05	0.96	0.48	0.48	0.00	1.92	0.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	8.35	1.59	0.80	0.00	0.40	1.99	1.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	0.61	0.00	0.61	0.61	1.22	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.30	2.08	1.38	0.00	0.00	0.69	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.74	0.76	0.38	0.76	0.00	1.52	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	6.71	0.00	0.52	0.00	0.00	1.03	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	0.60	0.60	0.00	0.00	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.04	1.58	0.00	0.32	1.27	1.58	1.58	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	6.93	0.53	0.53	0.53	0.53	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.90	0.57	1.15	0.00	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	0.00	1.03	0.51	0.00	1.03	1.03	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	1.41	0.00	0.71	0.00	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.81	0.57	0.57	0.00	0.57	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.74	0.83	0.42	0.00	0.42	1.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	4.70	0.78	0.00	0.00	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	0.84	0.84	0.42	0.84	0.84	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	10.69	1.39	0.00	0.00	0.00	0.93	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	0.00	0.00	0.00	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.88	1.60	0.53	0.53	0.53	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.87	1.21	0.81	0.40	0.00	0.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	2.75	0.00	0.00	0.00	0.00	1.84	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	0.00	0.89	0.00	0.00	1.78	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	4.56	0.00	0.00	0.57	0.57	1.71	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	4.60	1.53	0.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.21	2.19	0.00	0.55	1.64	0.55	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.90	0.89	0.89	0.89	0.00	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	5.46	1.30	0.52	0.00	0.00	0.78	0.78	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	6.63	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	0.00	0.00	0.00	6.24	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.98	5.70	2.28	2.96	1.82	0.91	0.91	0.68	0.23
Macrophage - monocyte derived, donor2	11313-117C8	11.74	4.40	1.28	1.10	0.92	0.55	0.18	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	14.68	6.16	1.97	2.49	1.18	0.13	0.79	0.26	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	0.53	0.00	0.00	0.00	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	20.76	3.64	1.43	0.48	0.63	1.43	0.79	0.16	0.48
Mallassez-derived cells, donor3	11930-125I4	24.32	4.17	2.08	2.08	0.56	1.81	2.50	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	35.67	9.77	5.48	3.39	3.79	4.38	3.49	1.30	0.80
Mammary Epithelial Cell, donor2	11350-117G9	39.38	6.95	2.90	2.03	2.90	2.32	4.05	0.29	1.16
Mammary Epithelial Cell, donor3	11422-118F9	7.48	3.24	0.50	0.25	0.75	0.25	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	277.28	75.93	83.39	35.25	37.96	10.85	16.27	2.03	7.46
Mast cell, donor1	11563-120D6	32.01	17.74	10.06	12.00	3.46	3.24	3.89	0.54	0.76
Mast cell, donor2	11565-120D8	32.09	31.80	29.42	24.07	12.18	6.84	8.92	1.78	3.57
Mast cell, donor3	11566-120D9	28.14	38.50	35.12	29.27	14.63	6.75	8.10	2.70	5.85
Mast cell, donor4	11567-120E1	26.59	26.95	20.74	22.16	5.85	6.03	6.56	2.30	2.48
Mast cell, expanded and stimulated, donor5	11940-126A5	27.39	11.53	5.21	3.88	3.33	3.22	3.11	1.33	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	40.27	12.26	7.59	2.92	1.75	1.75	0.58	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	15.37	12.39	6.77	3.79	1.49	0.92	2.06	0.57	0.69
Mast cell, expanded, donor8	11941-126A6	23.60	14.39	7.87	2.68	1.84	0.67	2.68	0.50	0.84
Melanocyte - dark, donor1	11502-119F8	27.56	13.83	4.68	8.76	2.89	1.69	2.98	0.00	0.99
Melanocyte - dark, donor2	11582-120F7	14.54	1.38	3.11	3.11	1.38	0.35	0.35	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	41.07	14.92	6.16	8.84	2.10	2.25	2.25	0.07	0.51
Melanocyte - light, donor1	11274-116H5	6.58	1.65	0.24	1.41	0.47	0.71	0.47	0.24	0.00
Melanocyte - light, donor2	11351-117H1	3.41	2.05	0.68	0.00	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	4.34	0.00	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	18.43	6.14	2.81	2.71	1.25	1.35	1.15	0.00	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	23.94	5.92	4.57	1.61	2.69	1.88	0.54	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	12.86	8.04	3.21	3.48	2.41	0.54	0.27	0.00	1.87
Meningeal Cells, donor1	11493-119E8	57.94	6.95	4.96	2.98	1.74	3.23	3.47	0.12	0.37
Meningeal Cells, donor2	11573-120E7	29.05	7.04	3.08	3.96	2.20	2.20	1.32	0.00	0.88
Meningeal Cells, donor3	11654-122E7	90.55	10.84	8.23	3.67	3.59	4.40	4.65	0.00	1.14
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	44.77	9.70	8.84	4.85	3.42	3.42	3.99	0.86	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.37	3.92	3.22	1.11	1.61	0.20	0.30	0.00	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	2.15	3.59	1.44	1.44	1.44	2.15	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.49	3.60	2.54	2.12	1.48	0.21	0.21	0.21	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.08	3.52	3.52	1.01	1.51	0.00	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	23.73	3.52	1.76	2.42	0.22	2.20	1.10	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	21.92	5.11	0.00	0.00	1.46	0.73	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.91	1.43	1.02	0.20	0.20	0.61	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.59	7.62	4.16	3.74	1.39	0.83	2.77	0.14	1.39
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.46	0.74	0.00	0.37	0.37	0.00	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.55	5.26	4.34	2.11	1.97	1.05	0.79	0.79	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	1.19	0.59	0.00	0.30	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	3.20	1.28	0.00	1.92	0.64	0.64	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	47.50	6.03	3.19	2.84	1.06	3.19	1.06	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	8.13	4.38	3.13	3.75	2.19	0.00	1.88	1.25	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.12	6.53	4.35	1.45	2.90	5.08	1.45	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	11.14	1.59	0.27	0.53	0.27	1.06	0.80	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	9.01	1.00	0.50	1.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.84	1.88	0.72	1.01	0.79	0.72	0.79	0.07	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	5.40	0.00	0.00	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	7.39	5.42	1.23	1.97	1.23	0.25	0.74	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	5.01	1.47	0.88	0.29	0.59	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.75	3.41	1.55	1.55	0.31	0.31	0.62	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.81	3.32	1.04	0.41	0.00	0.41	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	2.32	0.00	0.00	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.51	4.25	1.50	1.25	0.50	0.75	1.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.38	4.19	0.00	0.93	0.47	0.47	0.93	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.71	4.06	0.61	1.22	0.20	0.41	1.02	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.75	2.38	1.58	0.00	0.40	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	0.88	1.77	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.80	1.52	1.90	0.00	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	1.32	0.00	0.00	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.09	5.09	1.49	0.21	0.21	0.42	0.21	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.92	0.92	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.77	1.79	0.89	0.30	0.89	0.60	0.60	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	1.68	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	6.27	3.51	2.26	0.50	1.00	0.50	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.57	2.38	1.66	0.95	0.00	0.48	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.42	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.22	2.30	1.15	0.92	0.00	0.23	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.47	1.68	0.00	0.00	0.42	0.21	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	4.08	0.82	1.22	0.82	0.41	0.41	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.29	3.22	1.07	1.07	0.00	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.00	2.67	0.22	0.44	0.22	0.00	0.67	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.48	1.10	0.88	0.22	0.00	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.04	1.52	0.51	0.00	1.01	0.51	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	1.66	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	4.35	1.63	0.82	0.82	0.27	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.88	1.76	0.00	0.59	0.88	0.88	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.96	0.00	0.48	0.48	0.48	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.20	1.60	1.20	0.00	0.00	0.80	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.00	0.50	1.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.50	0.44	0.44	0.00	0.00	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	2.21	0.00	0.00	0.00	0.00	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	1.28	0.00	0.64	0.00	1.28	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.21	0.74	0.25	0.50	0.00	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	0.70	0.00	0.70	0.70	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.55	2.05	0.34	0.34	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	3.06	1.75	0.00	0.00	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	1.42	1.07	0.00	0.00	0.71	1.07	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.10	1.12	1.12	0.28	0.56	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.99	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.75	0.58	0.00	1.17	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.24	0.60	0.00	0.60	0.00	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	1.25	0.00	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	8.31	4.62	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	1.14	0.00	0.00	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.75	2.63	0.97	0.83	1.24	0.55	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	2.33	1.04	0.52	1.55	0.00	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.01	1.29	0.43	0.43	0.86	0.00	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	2.54	1.27	1.27	0.64	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.54	2.67	0.80	0.53	0.53	0.80	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.88	3.29	1.20	0.30	0.60	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.71	4.10	1.70	1.41	0.28	0.14	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.64	1.27	0.64	0.96	0.64	0.64	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.15	3.10	1.11	0.44	0.22	0.88	0.22	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	3.41	1.14	1.14	1.14	0.76	0.00	1.14	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	3.13	0.57	1.99	0.28	0.57	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.08	3.44	0.74	1.47	0.74	0.49	0.98	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.17	3.91	0.65	1.96	2.61	0.65	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	13.82	6.76	1.47	1.47	0.59	0.88	0.88	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.51	3.17	0.86	0.58	0.00	0.00	1.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.61	15.25	3.71	4.53	1.24	1.65	1.65	0.41	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.23	4.47	2.38	0.60	0.00	0.30	0.60	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	0.00	7.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	8.91	1.78	1.78	0.00	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.61	7.89	3.29	0.99	1.31	0.33	0.66	0.99	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	2.10	1.05	0.00	0.00	1.05	1.05	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	2.17	2.77	0.99	0.40	0.20	0.00	0.20	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	1.86	0.00	0.93	0.00	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	3.00	4.13	2.63	1.88	2.25	0.38	0.38	0.00	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.73	1.86	0.27	0.00	0.27	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	6.67	5.88	2.04	1.36	0.11	0.11	0.57	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	0.74	0.74	0.74	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.60	2.93	0.73	1.10	0.00	0.37	0.37	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	3.11	4.67	3.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.29	9.09	3.21	0.53	0.53	0.00	0.53	1.07	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	3.86	0.00	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	2.02	0.00	2.02	1.01	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	2.53	1.69	2.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	6.81	2.72	1.36	4.09	1.36	2.72	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	5.09	3.81	1.91	1.27	2.54	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	13.77	12.15	4.86	0.00	1.62	0.00	0.00	0.81	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	6.04	0.00	1.51	3.02	1.51	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	5.71	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	0.00	3.26	6.52	0.00	3.26	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	4.75	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	12.55	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	18.10	3.66	3.23	2.15	1.08	0.43	1.29	0.00	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.07	5.23	3.66	1.57	3.14	1.05	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	2.67	2.00	0.67	0.67	0.00	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.35	3.34	0.83	1.25	0.42	0.00	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	60.85	7.80	6.85	4.56	6.27	4.18	3.23	0.00	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	27.13	11.17	1.60	4.79	3.19	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.04	1.36	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	154.36	18.38	12.86	12.86	11.03	3.68	3.68	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.67	0.42	1.67	0.84	2.51	0.42	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.50	4.42	1.39	1.16	2.79	0.93	1.16	0.23	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.78	2.16	1.62	0.81	2.97	0.27	0.00	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.24	7.15	2.73	1.47	4.84	0.63	0.63	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	400.85	100.21	100.21	55.67	55.67	22.27	11.13	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.47	0.00	0.50	0.50	0.50	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.77	2.71	1.62	1.08	0.81	0.27	1.08	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	1.81	1.36	0.45	1.13	0.23	0.23	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.27	1.80	1.31	0.65	0.65	0.16	0.33	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.30	4.92	1.64	1.28	0.91	0.18	1.64	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	2.12	0.53	1.06	0.00	1.06	0.00	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.80	1.80	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	14.11	8.53	4.92	0.98	1.97	1.31	0.98	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	1.46	0.81	0.81	0.33	0.16	0.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	10.58	4.06	2.47	2.47	1.59	0.18	0.71	0.00	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	0.70	0.00	0.70	0.00	1.41	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.84	1.38	1.84	0.46	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	2.57	1.93	1.61	0.96	0.00	0.32	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.83	6.21	1.38	0.69	0.69	1.38	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	113.78	25.28	22.76	12.64	5.06	0.00	10.11	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	6.46	3.79	0.89	0.67	0.89	0.22	0.22	0.00	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.39	0.00	0.85	0.00	2.12	0.00	0.85	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.75	1.90	0.95	0.24	0.47	0.71	0.47	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	2.58	1.72	0.86	1.72	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	252.78	9.03	0.00	18.06	45.14	18.06	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	1.67	1.33	1.33	0.33	1.33	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	5.86	1.80	0.90	1.35	0.90	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.57	0.40	1.59	0.00	1.19	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	0.93	0.93	0.93	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.05	1.51	1.14	1.51	0.76	1.14	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	1.63	0.98	0.33	0.33	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1.31	0.87	0.87	0.44	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	3.17	2.71	1.36	2.26	1.36	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	1.76	0.00	0.00	1.76	0.00	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	1.33	1.99	1.99	0.66	0.66	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.98	3.97	0.99	0.50	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	1.15	0.38	0.38	0.00	0.00	0.38	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.14	3.33	1.21	0.60	0.30	0.00	0.60	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.49	2.87	1.11	0.88	1.33	0.00	0.22	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	0.68	0.68	0.68	0.00	0.00	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	15.33	5.11	0.00	5.11	15.33	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	1.22	1.22	0.00	1.22	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.35	0.63	0.31	1.57	0.00	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	1.82	0.61	1.21	1.21	0.61	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.96	0.00	1.58	2.37	1.58	0.79	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	3.40	2.27	3.40	7.94	1.13	2.27	1.13	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	15.17	5.06	10.12	10.12	10.12	15.17	0.00	0.00
Myoblast, donor1	11241-116D8	26.09	3.35	1.99	1.86	1.99	0.87	0.75	0.25	0.12
Myoblast, donor2	11322-117D8	28.00	4.60	3.64	1.15	2.11	0.77	1.53	0.38	0.77
Myoblast, donor3	11398-118D3	53.64	7.06	4.04	4.54	3.53	3.20	1.01	0.17	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	100.26	14.89	11.38	8.46	6.13	7.44	1.46	7.88	1.75
Natural Killer Cells, donor1	11230-116C6	30.14	20.30	17.84	10.46	8.61	1.85	2.46	4.00	4.00
Natural Killer Cells, donor2	11311-117C6	25.33	14.17	9.35	9.95	11.46	2.11	1.21	3.32	2.41
Natural Killer Cells, donor3	11387-118C1	19.14	11.96	13.25	8.65	7.18	2.94	1.84	3.31	3.50
Neural stem cells, donor1	11275-116H6	58.43	32.30	41.38	12.34	41.01	3.63	2.54	0.36	13.79
Neural stem cells, donor2	11352-117H2	88.58	23.11	34.66	7.70	26.96	7.70	1.93	0.00	5.78
Neurons, donor1	11494-119E9	37.55	12.52	13.65	2.28	5.69	0.00	0.00	0.00	3.41
Neurons, donor2	11574-120E8	25.76	8.37	5.28	3.52	5.06	4.18	1.98	0.44	1.32
Neurons, donor3	11655-122E8	21.38	9.04	4.11	2.47	11.51	3.29	0.00	0.00	1.64
Neutrophils, donor1	11233-116C9	12.99	6.50	6.50	2.78	0.93	0.93	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	11.60	2.90	2.90	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	49.48	30.54	11.61	13.44	3.67	0.61	1.83	2.44	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	6.89	6.53	4.39	2.85	2.97	1.54	2.85	0.24	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	1.95	2.28	3.91	1.30	1.95	0.65	0.00	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	6.82	5.01	2.01	1.80	0.40	1.60	1.60	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	7.98	2.62	2.89	0.96	0.83	0.28	0.69	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	15.78	5.21	2.61	0.87	2.32	1.16	0.72	0.43	0.72
Olfactory epithelial cells, donor3	11935-125I9	6.92	2.72	2.72	0.79	1.14	0.45	0.11	0.23	0.45
Olfactory epithelial cells, donor4	11936-126A1	12.76	3.12	2.73	1.75	2.34	1.27	0.49	0.29	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	34.30	9.03	3.01	5.42	1.20	1.20	2.41	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	4.47	1.91	0.85	0.43	0.43	0.64	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	0.00	1.14	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	1.24	0.62	0.00	1.24	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	4.69	1.37	0.98	0.20	0.59	0.20	1.17	0.00	0.00
Osteoblast, donor2	11354-117H4	74.45	16.15	11.24	2.11	5.62	4.21	2.11	0.00	0.70
Osteoblast, donor3	11426-118G4	12.97	2.13	1.96	1.60	1.78	0.89	0.36	0.18	0.71
Pancreatic stromal cells, donor1	11249-116E7	27.71	5.39	4.46	3.20	2.70	1.52	1.60	0.17	0.76
Pericytes, donor1	11491-119E6	2.34	0.67	0.89	0.78	0.22	0.22	0.33	0.00	0.22
Pericytes, donor2	11571-120E5	1.58	0.68	0.68	1.36	1.13	0.23	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	5.70	0.61	0.41	0.20	0.20	0.20	0.00	0.00	0.20
Perineurial Cells, donor1	11499-119F5	43.29	8.70	5.76	6.44	3.16	3.39	4.86	0.11	1.13
Perineurial Cells, donor2	11579-120F4	34.50	9.75	3.50	5.15	3.31	0.83	1.29	0.09	0.92
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.82	28.05	16.26	8.61	9.88	2.87	3.51	1.91	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	11.02	8.08	6.37	3.67	3.92	0.73	1.96	1.47	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.91	11.65	6.73	6.21	4.14	1.55	1.55	1.29	1.29
Placental Epithelial Cells, donor1	11278-116H9	6.94	1.20	0.96	0.48	0.48	0.48	0.48	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	24.40	2.22	1.11	4.44	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.44	2.36	1.37	1.37	1.96	1.57	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.38	0.32	1.27	0.32	0.63	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	10.32	1.88	1.31	0.38	0.38	0.38	0.38	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.58	5.22	2.61	2.35	1.17	0.78	0.52	0.26	0.52
Preadipocyte - breast, donor2	11328-117E5	10.36	1.80	0.90	0.90	0.68	0.00	0.23	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	12.68	2.66	1.81	1.07	1.70	0.00	0.64	0.11	0.85
Preadipocyte - omental, donor2	11329-117E6	12.66	5.24	2.18	3.49	2.18	0.44	1.31	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	15.18	2.44	1.43	1.29	0.72	0.86	0.72	0.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	1.97	0.00	0.00	0.00	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	9.21	2.15	0.31	0.31	0.00	0.31	0.31	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	54.01	9.03	5.49	4.96	3.36	2.48	1.24	0.35	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	18.90	4.09	4.43	3.24	2.89	0.85	0.51	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	64.09	9.97	9.22	4.75	4.66	2.05	2.79	0.56	1.12
Preadipocyte - visceral, donor2	11357-117H7	28.07	7.36	6.44	4.60	3.68	2.30	0.00	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	27.79	4.81	4.18	2.30	2.09	1.57	1.57	0.42	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.60	2.72	1.06	0.91	1.81	1.06	1.06	0.15	0.30
Prostate Epithelial Cells, donor2	11331-117E8	7.45	2.30	0.95	0.54	0.81	0.41	0.54	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	5.70	4.16	1.53	2.51	0.98	1.35	0.98	0.12	0.37
Prostate Stromal Cells, donor1	11254-116F3	43.28	4.90	4.44	2.73	3.99	0.91	0.68	0.80	0.80
Prostate Stromal Cells, donor2	11332-117E9	53.97	4.66	5.38	3.05	5.20	1.43	0.54	1.08	1.61
Prostate Stromal Cells, donor3	11405-118E1	8.24	2.09	2.09	1.04	0.94	0.31	0.73	0.42	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	1.82	0.36	0.36	0.00	0.36	1.82	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	23.50	5.54	2.70	1.87	1.32	2.91	2.56	0.28	0.49
Renal Epithelial Cells, donor1	11517-119H5	5.07	1.01	0.00	0.00	0.51	1.01	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	2.13	1.42	2.13	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	29.22	6.88	5.40	3.60	2.65	3.07	3.92	0.21	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	2.72	0.00	0.00	0.68	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.41	4.18	1.35	1.75	0.94	0.94	0.40	0.00	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	41.96	6.66	4.66	2.44	4.44	3.11	2.66	0.00	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	2.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.36	3.74	0.88	0.66	0.66	1.10	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.76	3.13	1.25	0.63	0.00	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	0.83	0.28	0.28	0.28	0.00	0.28	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.23	4.56	1.07	2.15	0.54	2.42	1.61	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.80	2.11	0.00	0.42	0.42	1.27	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.73	1.93	0.96	0.77	1.16	0.58	1.54	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	28.78	9.33	3.89	4.15	1.04	4.93	5.44	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	14.50	6.25	1.42	1.71	1.42	0.28	1.71	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	1.03	1.03	0.00	2.06	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.29	5.27	3.76	2.01	2.51	0.75	1.00	0.00	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	14.03	7.35	6.55	4.01	3.34	2.14	1.20	0.13	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	19.65	7.15	1.79	5.36	0.00	0.89	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	130.99	37.98	26.97	3.85	11.56	7.15	3.85	3.30	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	131.09	44.66	27.84	8.70	11.60	13.34	5.80	6.96	7.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	241.07	41.22	17.94	13.13	8.32	15.21	9.62	0.39	3.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	106.36	16.29	10.33	5.46	7.15	6.36	3.38	0.89	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	177.46	26.99	15.06	11.27	8.92	8.37	4.13	0.45	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	226.63	33.86	17.12	18.85	12.65	16.62	8.68	1.12	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	112.82	18.18	13.17	5.48	7.11	4.78	2.10	0.12	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	146.31	24.96	13.87	9.94	8.32	9.01	4.16	1.39	4.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	138.00	24.78	9.31	9.04	5.61	11.09	4.11	0.41	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	121.32	21.63	13.61	6.35	8.17	4.84	3.78	0.30	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	130.27	20.43	12.18	5.73	7.17	5.02	3.76	0.36	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	128.11	19.94	8.75	6.74	6.17	9.32	3.44	0.72	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	98.51	14.49	10.95	4.94	5.26	6.87	3.97	0.43	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	92.27	17.48	12.83	5.31	7.30	7.08	3.32	0.89	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	139.75	23.90	8.22	6.50	6.88	6.31	4.59	0.38	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	110.49	17.05	11.27	6.89	8.20	6.34	3.35	0.47	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	206.51	30.25	22.92	9.77	9.21	8.27	7.33	0.75	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	123.42	20.30	7.83	8.36	5.71	8.49	3.72	0.53	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	133.36	19.66	11.10	8.47	7.59	8.57	3.99	0.88	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	134.05	19.29	9.36	7.45	6.30	8.21	3.25	0.95	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	130.72	20.72	9.40	7.80	5.98	8.33	5.77	1.17	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	103.71	16.54	10.37	3.92	4.77	5.61	2.52	0.00	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	137.06	19.48	10.77	6.15	8.37	6.49	4.79	0.68	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	114.32	17.69	8.20	7.29	5.29	8.57	2.73	1.28	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	102.40	11.65	9.69	6.74	6.50	7.24	2.58	0.61	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	116.86	17.46	10.88	5.91	4.84	7.66	3.22	0.40	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	160.87	22.88	12.97	7.31	6.60	8.02	4.95	0.94	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	109.92	18.25	10.32	6.94	7.74	6.15	2.38	0.79	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	116.69	14.73	11.69	6.31	5.85	6.78	5.85	0.23	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	145.15	19.28	8.71	7.05	4.98	9.95	4.15	0.00	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	128.08	18.80	8.63	4.20	8.63	6.86	5.53	0.00	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	114.47	15.25	8.77	5.43	6.68	7.31	2.51	0.42	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	154.37	19.11	8.88	7.81	4.58	8.48	4.98	0.40	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	133.00	19.07	9.71	5.62	9.37	8.34	4.26	0.34	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	139.97	17.54	11.18	5.01	7.33	7.52	3.47	0.77	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	174.86	22.52	10.32	5.67	6.19	9.63	3.61	0.52	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	124.82	19.48	11.25	5.49	6.72	7.68	4.53	0.41	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	145.95	21.01	13.46	6.24	8.21	8.87	6.07	0.49	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	138.22	22.84	9.88	8.18	4.09	11.08	3.58	0.34	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	142.19	25.60	13.91	6.95	8.43	10.21	4.88	0.59	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	114.62	18.39	11.99	9.60	6.93	6.40	3.20	0.80	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	102.59	18.53	10.23	8.85	6.08	9.96	4.01	0.83	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	74.53	16.67	7.38	6.67	3.81	8.33	2.38	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	125.16	24.59	12.50	9.88	8.26	9.88	4.84	1.41	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	84.29	13.28	6.69	6.97	3.39	7.35	3.39	0.66	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	76.51	12.93	13.63	5.94	5.94	7.34	5.59	0.00	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	63.46	15.72	10.28	4.23	6.65	6.04	3.32	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	74.53	13.58	6.61	5.51	4.65	8.08	4.28	0.49	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	184.12	31.15	18.78	10.63	15.43	18.19	7.86	2.18	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	61.45	13.99	10.34	7.91	2.43	10.34	4.26	2.43	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	80.77	16.88	4.82	6.63	2.11	6.93	1.81	0.90	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	54.74	9.73	7.46	3.62	3.17	5.20	2.49	1.13	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	68.30	13.78	8.99	6.89	7.19	9.29	2.40	2.40	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	56.79	16.06	8.62	5.67	3.66	9.09	4.49	1.18	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	44.40	10.46	6.62	2.35	5.34	5.34	3.20	0.85	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	57.69	16.83	11.42	7.21	6.01	8.41	3.00	3.61	1.80
Schwann Cells, donor1	11498-119F4	11.85	1.50	0.75	0.38	0.19	1.50	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	17.01	3.40	10.21	0.00	3.40	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	40.97	7.45	3.51	2.85	1.75	2.63	1.31	0.22	0.44
Sebocyte, donor1	11220-116B5	9.86	3.83	1.64	1.10	1.10	0.55	0.55	0.00	0.55
Sebocyte, donor2	11301-117B5	11.03	2.76	1.38	1.84	0.00	1.38	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	5.15	0.41	0.62	0.62	0.21	0.41	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	38.10	0.00	3.31	1.66	1.66	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	2.82	2.82	5.65	0.00	2.82	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	12.23	4.40	2.46	1.67	1.50	1.41	1.67	0.26	0.44
Skeletal Muscle Cells, donor2	11358-117H8	0.00	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	4.18	2.51	0.84	2.51	2.51	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	41.47	8.33	5.03	5.03	3.14	3.14	2.51	0.00	0.79
Skeletal Muscle Cells, donor5	11455-119A6	33.89	9.36	3.72	3.72	3.27	2.38	4.16	0.30	0.89
Skeletal Muscle Cells, donor6	11459-119B1	54.17	10.77	2.77	4.00	2.31	4.00	2.46	0.46	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	38.31	13.10	9.07	4.66	4.41	3.28	3.53	1.26	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.54	7.85	4.28	3.85	3.42	3.00	1.43	0.43	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	51.69	7.74	5.06	3.37	2.88	3.97	3.08	0.00	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	25.78	5.64	6.74	2.36	3.96	2.27	1.69	0.17	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.90	1.45	1.45	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	1.93	1.93	0.96	1.10	0.28	0.14	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	13.43	10.74	16.12	2.69	8.06	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.18	0.86	0.29	0.29	0.00	0.43	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	6.54	0.00	0.00	0.00	0.00	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.45	2.60	0.78	0.39	0.39	0.13	0.26	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.76	2.64	2.09	0.56	0.42	0.42	1.53	0.00	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	6.47	1.83	0.98	1.69	0.98	0.56	0.98	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.20	9.09	3.17	6.13	1.90	1.27	2.54	0.63	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	4.42	1.20	1.57	1.27	0.82	1.12	1.50	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.49	2.78	1.23	2.47	0.62	1.54	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.23	2.45	2.22	2.45	1.11	1.33	0.67	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.88	2.35	1.18	0.00	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	9.94	2.43	1.77	0.44	0.00	0.66	0.44	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	5.91	1.18	0.39	0.00	0.00	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	0.77	0.00	1.55	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	3.00	2.00	2.00	2.00	0.00	1.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.92	2.13	0.93	0.93	0.40	0.27	0.27	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.30	4.88	2.44	3.10	2.66	1.55	0.00	0.00	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.96	3.07	1.54	1.92	1.15	0.90	0.38	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.98	5.54	4.56	2.60	1.95	2.60	1.63	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.44	7.38	2.95	5.32	0.89	2.95	2.95	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6.98	2.42	1.85	1.42	0.57	0.28	0.71	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.07	1.63	0.00	0.00	0.16	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	5.48	2.44	1.52	2.44	0.91	0.91	1.22	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.04	2.02	0.51	0.76	0.25	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	128.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	0.95	0.95	0.48	0.00	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.42	5.31	5.16	2.06	1.92	1.18	1.33	0.59	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.71	3.66	3.66	2.58	1.29	0.43	1.08	0.65	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	21.20	5.98	3.46	2.52	2.41	1.68	1.15	1.36	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.64	0.77	0.31	0.00	0.00	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	4.31	1.08	1.08	1.08	2.16	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	2.09	0.30	1.20	0.00	0.30	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.56	0.34	0.68	1.37	0.34	1.37	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	11.62	6.20	4.40	2.67	2.51	0.71	1.26	0.47	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.27	6.84	4.43	2.82	4.43	0.91	1.21	0.20	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.74	3.41	0.91	1.59	0.91	1.59	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1.21	0.60	0.60	0.00	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	167.70	18.28	10.33	8.74	4.24	6.09	6.62	0.79	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	46.47	10.12	3.86	3.60	3.86	2.00	2.93	0.80	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.03	5.13	2.63	1.88	1.88	0.63	0.38	0.25	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.33	3.04	1.52	1.01	0.76	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	18.70	5.73	2.56	1.96	2.11	1.51	1.06	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	27.14	2.58	1.29	2.58	0.00	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.70	3.26	1.40	0.47	0.47	1.86	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	7.57	1.51	0.50	1.01	1.01	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3.45	1.88	0.63	0.31	0.00	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	0.59	0.88	0.29	0.00	0.00	0.29	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	119.05	12.66	7.75	9.25	4.75	8.08	6.33	0.58	1.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.07	6.07	4.67	2.34	1.87	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.48	1.30	0.43	0.29	0.00	0.58	0.29	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.90	1.53	1.78	0.51	0.25	0.51	0.76	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.89	0.94	0.38	1.13	1.13	0.75	0.19	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	69.87	14.95	5.03	7.55	3.07	5.31	5.17	1.26	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.93	6.28	3.02	4.02	1.68	1.17	1.01	0.42	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1.43	0.48	0.00	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	5.14	0.73	0.49	0.00	0.24	0.00	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.65	3.54	3.98	3.09	1.55	1.10	0.88	0.44	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	40.67	6.44	2.34	4.10	1.76	1.76	0.00	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2.92	2.92	0.78	0.19	1.17	0.58	0.58	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	3.17	0.53	0.26	2.12	0.00	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.53	5.95	3.35	1.49	2.23	0.37	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	6.83	3.95	0.36	0.36	1.08	0.36	0.72	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.26	3.12	0.85	0.00	1.14	0.00	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	33.48	5.91	3.15	0.39	3.94	0.79	0.39	0.39	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	5.08	5.59	1.52	1.27	1.52	0.25	0.25	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	6.39	2.80	0.40	0.80	0.00	0.80	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	2.09	1.67	0.84	1.25	0.84	0.00	0.00	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	2.75	0.92	0.00	0.00	0.00	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	18.68	3.53	6.06	1.18	4.21	1.18	0.84	0.00	1.35
Synoviocyte, donor2	11368-117I9	7.71	2.68	1.34	0.84	0.17	0.50	0.34	0.17	0.17
Synoviocyte, donor3	11440-118H9	5.36	1.79	0.22	0.89	0.67	1.34	0.22	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	25.01	1.79	2.14	1.43	0.36	0.71	0.36	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.03	0.93	0.69	0.69	0.46	0.46	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	10.97	2.65	1.86	1.22	0.86	0.43	1.15	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	2.32	1.93	0.00	0.39	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	0.57	0.00	0.00	0.57	0.57	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	13.16	7.87	5.29	4.67	3.20	1.35	1.85	0.25	1.60
Urethra, donor2	10319-105A4	10.79	5.40	3.60	1.80	10.79	1.80	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	3.19	0.80	0.00	0.00	0.00	0.80	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	1.60	0.00	0.00	0.40	0.40	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	0.92	0.23	0.00	0.00	0.00	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	7.36	3.79	3.57	1.78	0.67	1.56	2.23	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	59.62	16.91	11.57	16.91	2.67	2.67	0.89	0.89	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	54.33	24.30	11.44	12.87	0.00	2.86	5.72	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	20.54	10.95	2.74	3.42	2.05	0.68	2.05	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.65	21.00	8.61	5.17	4.13	1.38	1.72	1.72	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	17.43	10.46	8.72	2.91	2.32	1.74	0.58	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	23.95	10.41	12.49	1.04	2.08	2.08	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	59.66	35.79	18.36	5.51	4.59	1.84	2.75	2.75	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	10.04	4.56	6.39	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	37.38	13.69	15.91	11.60	15.54	2.59	1.23	0.37	4.32
Wilms' tumor cell line:HFWT	10597-108E3	10.56	0.88	2.64	0.00	0.88	2.64	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	30.45	10.61	3.07	1.96	1.96	4.47	1.12	1.96	1.40
achilles tendon, donor2	10292-104G4	10.33	6.20	4.13	4.13	8.27	2.07	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	107.85	46.40	22.95	23.46	17.08	4.33	2.29	1.02	5.10
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	176.45	74.30	28.56	29.02	13.93	12.77	8.59	0.70	3.02
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	186.61	37.39	27.07	14.84	19.94	9.02	4.27	5.22	6.65
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	146.67	40.00	13.33	9.52	9.80	5.44	4.63	1.63	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	59.59	29.79	31.20	10.68	17.71	2.25	0.84	1.12	8.71
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	71.06	14.17	13.11	5.50	6.98	1.48	1.27	1.69	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	31.03	26.68	16.88	10.34	10.89	0.54	0.27	0.54	2.45
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	51.55	26.88	10.58	10.58	8.37	1.32	0.44	0.44	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	26.14	23.28	21.23	9.39	8.58	0.82	0.41	2.86	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	40.77	20.19	13.59	14.37	7.77	1.16	0.39	1.94	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	93.10	31.28	21.90	8.83	9.38	4.23	1.29	2.76	2.21
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	11.70	11.70	7.80	7.80	3.90	0.00	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.04	27.89	17.20	9.30	9.06	1.16	1.86	0.00	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	103.30	39.09	31.33	7.77	20.97	3.88	2.33	2.33	6.73
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	90.01	36.53	33.61	9.94	17.24	4.97	2.05	1.46	6.14
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	36.72	15.34	5.58	1.39	5.58	2.32	2.32	4.65	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	139.00	23.44	16.45	8.23	10.69	2.06	1.65	1.65	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	31.31	9.21	8.29	3.68	5.53	2.15	1.53	0.92	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	107.96	29.44	21.34	11.95	11.52	7.68	3.84	4.27	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	116.77	33.36	23.05	13.95	7.89	8.49	5.76	5.46	3.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	128.06	35.87	28.88	19.74	15.16	4.09	3.37	3.13	3.37
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	164.38	43.88	29.62	9.36	16.48	3.79	2.00	4.01	8.02
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	120.74	17.34	8.34	1.67	6.00	6.34	5.34	0.67	3.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	55.75	57.60	27.87	16.72	27.87	5.57	3.72	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.40	16.95	12.05	4.90	5.27	4.90	4.14	0.38	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.27	34.89	17.45	9.59	12.65	4.80	2.62	0.87	7.41
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	56.23	56.23	20.62	41.24	22.49	1.87	1.87	1.87	3.75
adenocarcinoma cell line:IM95m	10796-110I4	39.56	24.49	10.36	9.42	2.12	5.89	5.89	0.24	1.41
adipose tissue, adult, pool1	10010-101C1	13.19	7.14	3.57	2.64	1.55	3.41	2.79	0.16	0.31
adipose, donor1	10184-103D4	66.85	83.27	41.64	46.91	33.43	7.62	5.28	1.76	15.25
adipose, donor2	10185-103D5	12.57	19.06	11.76	9.33	8.11	1.62	0.41	0.00	4.87
adipose, donor3	10186-103D6	34.85	20.15	17.43	10.62	14.16	3.54	2.45	0.27	2.72
adipose, donor4	10187-103D7	123.95	14.73	10.40	2.60	9.53	8.67	6.07	0.00	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	57.45	30.62	6.15	10.89	4.10	10.26	7.73	1.10	1.26
adrenal gland, adult, pool1	10081-102A9	10.91	0.00	7.28	0.00	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	71.51	19.74	14.27	6.67	5.87	7.47	5.07	6.00	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	56.45	3.57	2.86	1.79	0.71	3.57	2.86	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	12.75	6.49	3.25	4.64	1.85	4.41	3.25	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	34.15	5.07	5.41	3.38	3.04	4.40	2.03	0.00	1.35
amniotic membrane cells, donor3	12237-129G5	11.49	7.66	3.24	5.01	0.88	2.65	4.12	0.29	0.00
amygdala - adult, donor10196	10167-103B5	29.64	14.23	8.30	2.37	3.56	7.11	7.11	1.19	1.19
amygdala, adult, donor10252	10151-102I7	30.01	11.76	2.84	4.66	3.04	9.73	6.49	1.22	1.22
amygdala, newborn, donor10223	10360-105E9	6.46	4.52	1.94	1.29	2.58	0.97	0.97	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	4.58	3.06	1.02	1.15	0.89	1.02	0.25	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	132.82	29.12	26.47	19.19	19.64	3.31	3.09	4.41	4.85
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	84.51	23.38	11.02	10.36	7.68	10.02	2.67	0.33	5.01
aorta, adult, pool1	10052-101G7	12.94	13.14	6.28	8.63	4.31	2.75	3.73	0.20	1.57
appendix, adult	10189-103D9	25.23	15.91	5.05	5.05	6.21	2.72	1.94	0.00	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	19.26	7.91	3.44	4.47	0.69	3.78	3.44	0.34	0.34
artery, adult	10190-103E1	10.87	12.23	2.72	2.72	2.72	2.72	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	89.96	9.13	8.84	4.35	4.49	5.07	3.77	1.59	2.03
b cell line:RPMI1788	10427-106D4	91.45	26.77	19.78	9.52	8.33	7.73	6.54	3.87	3.42
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.32	1.66	2.77	2.22	1.39	0.28	0.00	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	51.10	9.53	5.56	3.08	2.98	3.77	2.98	1.19	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	39.00	6.03	4.18	2.51	0.67	4.35	1.51	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.93	15.10	10.63	6.15	9.51	0.56	1.12	2.80	0.56
bladder, adult, pool1	10011-101C2	17.38	15.86	7.93	8.80	4.78	4.13	3.69	0.54	0.54
blood, adult, pool1	10053-101G8	11.07	19.93	8.86	11.07	6.64	2.21	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	37.68	5.99	2.57	4.28	5.14	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	23.62	10.80	5.40	1.35	3.37	0.00	2.02	0.00	2.02
brain, adult, donor1	10084-102B3	9.23	6.15	1.03	1.03	0.00	5.13	5.13	1.03	0.00
brain, adult, pool1	10012-101C3	27.62	14.25	5.35	4.12	4.23	7.13	9.58	0.22	1.34
brain, fetal, pool1	10085-102B4	0.00	0.00	0.00	0.00	0.00	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.19	4.96	1.32	0.00	0.33	5.62	2.64	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.70	6.24	5.12	2.87	1.62	6.62	5.99	0.00	0.50
breast, adult, donor1	10080-102A8	5.68	5.05	2.53	3.16	0.63	0.00	1.89	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	48.40	18.55	5.97	5.84	1.40	5.08	6.86	0.00	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	61.23	27.21	13.61	9.28	4.33	9.28	7.73	0.00	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	69.76	12.66	2.53	2.07	1.61	3.91	4.37	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	30.99	11.62	7.99	6.29	4.36	3.15	3.63	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	44.67	27.74	8.93	7.05	2.82	10.81	4.23	0.94	0.94
carcinoid cell line:NCI-H727	10735-110B6	63.55	13.78	7.00	4.81	2.84	10.61	4.81	0.00	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	39.61	35.81	13.94	8.56	8.24	4.12	3.17	0.63	3.80
carcinosarcoma cell line:JHUCS-1	10642-109A3	91.03	26.35	20.76	18.10	19.70	13.04	7.45	0.53	4.79
caudate nucleus - adult, donor10196	10177-103C6	42.60	21.88	9.21	8.06	4.61	6.91	6.91	3.45	1.15
caudate nucleus, adult, donor10252	10164-103B2	39.82	14.06	6.19	4.69	3.51	9.87	8.70	2.34	0.67
caudate nucleus, adult, donor10258	10379-105H1	18.34	16.81	2.29	0.76	4.58	1.53	6.88	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.92	7.69	2.56	1.83	4.39	1.83	1.83	0.37	1.83
cerebellum - adult, donor10196	10173-103C2	37.87	81.57	40.79	11.65	17.48	17.48	26.22	0.00	5.83
cerebellum, adult, donor10252	10166-103B4	69.39	38.22	16.65	18.79	8.11	30.75	24.98	0.85	2.14
cerebellum, adult, pool1	10083-102B2	19.66	25.87	13.80	13.80	9.66	10.00	5.17	0.34	4.48
cerebellum, newborn, donor10223	10357-105E6	19.93	21.59	16.61	4.15	23.25	1.66	1.66	0.00	4.15
cerebral meninges, adult	10188-103D8	29.25	12.61	6.81	3.78	2.77	7.31	8.57	0.50	1.51
cerebrospinal fluid, donor2	10294-104G6	18.27	2.92	2.92	1.46	4.39	1.46	2.92	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	52.48	23.01	16.97	13.80	9.20	4.74	7.33	0.58	1.15
cervical cancer cell line:ME-180	10553-107I4	11.10	2.82	1.82	2.15	0.99	1.33	1.99	0.00	0.00
cervix, adult, pool1	10013-101C4	21.21	10.92	8.71	4.51	3.57	3.57	5.88	0.10	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	9.34	1.81	1.11	0.70	0.56	0.84	0.42	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	1.31	0.00	1.31	2.61	0.00	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	60.03	32.44	19.76	14.79	10.94	8.82	4.47	0.12	2.49
choriocarcinoma cell line:SCH	10785-110H2	73.80	7.76	6.41	4.31	2.34	7.39	4.07	0.62	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	24.43	9.72	3.08	4.51	0.71	5.22	6.40	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	11.97	7.69	1.99	5.13	1.99	0.57	1.14	0.28	1.14
chorionic membrane cells, donor2	12239-129G7	25.75	5.07	2.29	3.78	2.68	1.19	0.89	0.50	0.80
chorionic membrane cells, donor3	12240-129G8	6.04	7.14	7.14	7.14	6.59	1.10	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	57.56	15.15	15.15	9.09	9.09	2.02	1.01	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	90.09	37.84	41.11	31.31	14.60	2.88	2.50	0.58	4.99
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.29	33.79	23.23	20.49	10.98	2.53	2.96	1.48	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	79.09	11.04	5.14	4.88	1.80	9.24	6.93	0.26	1.54
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	90.70	14.51	7.01	4.11	2.66	8.47	7.26	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	104.25	14.25	5.90	5.90	2.85	7.13	4.68	0.41	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	104.83	8.24	5.01	4.71	1.47	4.12	8.54	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	111.29	52.39	63.07	38.83	29.45	5.21	5.47	0.78	5.47
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.14	10.29	7.09	4.34	3.43	3.43	1.37	0.91	0.69
clear cell carcinoma cell line:TEN	10636-108I6	38.69	11.62	5.21	5.90	5.55	1.56	1.39	0.52	0.52
colon carcinoma cell line:CACO-2	10513-107D9	26.91	8.05	2.38	4.03	0.55	1.65	1.10	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	246.29	98.44	38.01	37.25	18.62	26.23	21.28	1.52	6.08
colon, adult, donor1	10082-102B1	3.57	7.14	1.19	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	13.87	11.40	5.05	5.29	1.88	2.00	2.12	0.00	0.71
colon, fetal, donor1	10070-101I7	4.33	8.03	4.33	2.47	4.94	1.85	1.85	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	13.75	9.17	0.00	0.00	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	154.68	29.75	34.42	7.22	30.60	0.42	0.42	3.40	5.10
cord blood derived cell line:COBL-a 24h infection	10453-106G3	218.10	35.47	34.71	11.02	18.26	4.08	2.26	2.57	4.98
cord blood derived cell line:COBL-a untreated	10449-106F8	222.94	39.62	31.02	12.41	20.59	3.38	2.40	1.55	5.50
corpus callosum, adult, pool1	10042-101F6	40.69	11.94	6.19	3.65	2.99	10.50	8.73	0.55	0.55
cruciate ligament, donor2	10295-104G7	18.64	4.05	6.48	4.05	3.24	4.05	0.81	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	5.62	8.03	4.01	1.61	3.21	3.21	1.61	0.00	2.41
diencephalon, adult	10193-103E4	20.64	10.56	3.12	3.12	1.92	6.24	4.56	0.24	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	72.33	59.93	40.87	25.95	23.19	5.51	2.53	1.15	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	38.21	23.08	5.39	3.08	3.08	4.10	5.64	0.26	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	34.66	6.74	6.02	4.33	4.81	1.69	0.96	3.37	1.93
ductus deferens, adult	10196-103E7	13.95	17.94	5.98	2.49	3.49	0.50	4.49	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	7.20	5.76	7.20	1.44	4.32	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	5.89	7.36	8.09	2.21	2.94	0.74	3.68	0.74	0.74
dura mater, adult, donor1	10041-101F5	34.36	16.10	17.59	12.97	10.57	4.38	3.22	1.07	3.88
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	36.64	6.22	6.22	3.55	9.55	2.89	1.11	0.00	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	44.56	10.32	13.47	4.16	11.03	2.58	1.72	0.00	3.44
embryonic pancreas cell line:1B2C6	10604-108F1	20.35	2.47	0.00	1.23	1.23	2.47	3.08	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	9.99	1.82	0.91	0.61	0.00	2.12	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.20	0.62	0.93	0.00	0.93	2.78	1.23	1.85	0.31
embryonic pancreas cell line:2C6	10603-108E9	9.19	3.94	0.00	2.63	0.00	9.19	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.13	28.83	23.13	13.74	19.11	2.01	4.02	1.01	6.37
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	24.29	6.71	2.54	4.35	3.26	2.54	1.81	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	27.66	4.50	2.73	1.93	0.96	1.29	1.45	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	78.14	16.45	10.56	6.11	6.89	12.89	6.00	1.00	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	67.64	13.64	9.02	4.73	4.40	8.03	4.73	0.22	0.99
epididymis, adult	10197-103E8	16.12	5.44	4.81	3.77	1.67	3.35	3.14	1.47	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	47.55	9.76	4.08	2.48	3.73	2.66	3.55	1.60	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.52	5.11	1.18	0.79	1.18	0.79	1.18	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	91.08	17.04	9.17	9.70	4.19	6.55	5.11	0.79	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	81.59	17.22	7.97	8.37	6.20	9.65	6.30	1.28	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	79.65	18.26	10.53	7.73	6.50	8.96	4.15	1.34	1.57
esophagus, adult, pool1	10015-101C6	12.95	11.15	3.50	3.93	1.91	2.55	2.87	0.32	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.40	7.64	10.52	5.89	5.39	2.00	1.63	0.00	1.75
eye - muscle inferior rectus, donor1	10272-104E2	14.49	12.07	4.83	0.00	9.66	12.07	4.83	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	18.94	6.31	2.10	0.00	6.31	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	7.44	1.49	1.49	5.95	1.49	2.98	0.00	2.98
eye - muscle superior, donor2	10297-104G9	14.90	8.03	2.29	0.00	5.73	8.03	1.15	1.15	3.44
eye - vitreous humor, donor1	10268-104D7	13.12	7.29	5.83	4.37	1.46	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	13.22	21.10	8.64	14.24	3.05	3.81	3.56	0.00	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	25.90	7.44	2.05	1.41	0.90	2.31	1.15	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	50.57	5.94	1.66	0.71	1.19	3.09	1.66	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	29.74	16.23	5.72	3.85	3.19	7.88	10.32	0.75	1.78
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	95.78	30.33	15.31	8.11	15.61	9.01	6.61	0.30	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	28.53	6.77	2.74	1.65	1.65	3.29	5.21	0.82	0.27
gall bladder, adult	10198-103E9	8.45	5.55	2.90	1.93	1.69	2.41	3.38	0.00	0.97
gamma delta positive T cells, donor1	11937-126A2	33.28	24.70	17.18	11.27	6.98	2.15	3.22	3.22	1.61
gamma delta positive T cells, donor2	11938-126A3	21.29	20.17	15.69	7.10	9.34	0.75	2.24	1.87	2.99
gastric adenocarcinoma cell line:MKN1	10614-108G2	18.80	4.22	4.22	1.48	2.75	2.11	1.06	0.42	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.41	7.54	4.45	3.67	1.16	4.26	2.90	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	76.24	13.12	5.25	4.10	3.28	3.77	3.28	0.49	1.64
gastric cancer cell line:GSS	10560-108A2	11.90	10.98	1.83	4.58	0.92	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	60.08	26.27	12.79	10.28	11.19	5.25	2.97	0.46	4.11
giant cell carcinoma cell line:LU65	10487-107B1	5.62	5.51	2.52	2.07	0.23	1.03	1.15	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	30.65	5.46	2.10	1.40	0.84	3.78	3.78	1.68	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.19	10.48	3.49	4.24	0.75	3.24	1.00	0.50	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.68	13.41	6.76	2.53	7.28	1.90	1.58	1.69	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	68.67	13.06	5.48	5.20	4.35	3.09	2.53	1.54	2.25
glioblastoma cell line:T98G	10485-107A8	65.01	11.04	11.04	6.07	6.62	2.10	2.76	1.66	2.43
glioma cell line:GI-1	10413-106B8	40.12	6.74	6.44	3.81	3.22	0.88	2.05	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	23.33	14.58	1.46	5.10	2.92	7.29	6.56	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	57.36	14.16	2.44	6.35	2.69	16.60	14.65	3.17	0.49
globus pallidus, adult, donor10258	10367-105F7	10.95	5.48	0.00	0.00	1.37	2.74	5.48	0.00	4.11
globus pallidus, newborn, donor10223	10364-105F4	7.99	1.60	2.66	0.00	1.60	0.00	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	0.00	2.45	0.00	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.76	4.80	6.40	2.24	5.12	0.96	0.64	0.00	2.56
hIPS +CCl2, biol_rep1	14383-156B9	76.67	13.31	6.43	2.30	4.13	4.13	0.92	0.00	6.43
hIPS +CCl2, biol_rep2	14384-156C1	62.64	10.52	2.74	4.12	0.91	2.29	1.83	0.00	2.29
hIPS +CCl2, biol_rep3	14385-156C2	41.87	7.09	4.51	0.64	2.58	1.29	1.93	0.00	1.93
hIPS, biol_rep1	14380-156B6	119.29	20.12	8.62	1.44	4.31	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	40.47	17.15	2.06	0.69	0.00	1.37	2.06	0.69	1.37
hIPS, biol_rep3	14382-156B8	27.59	12.14	1.10	2.21	2.21	6.62	4.41	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	57.18	23.56	22.99	13.51	11.49	5.17	2.87	4.31	3.45
heart - mitral valve, adult	10205-103F7	17.64	10.16	6.28	4.19	4.19	2.39	4.19	0.60	1.20
heart - pulmonic valve, adult	10206-103F8	22.23	15.17	10.20	5.49	7.84	3.40	3.40	1.05	1.83
heart - tricuspid valve, adult	10207-103F9	12.49	9.16	1.67	6.66	2.50	0.00	2.50	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	16.12	6.73	4.29	3.88	2.45	1.22	1.02	0.41	1.02
heart, adult, diseased, donor1	10051-101G6	3.83	4.68	1.28	0.43	1.28	2.55	0.85	0.43	0.85
heart, adult, pool1	10016-101C7	11.04	5.06	4.37	5.29	1.15	1.84	1.38	1.15	0.69
heart, fetal, pool1	10046-101G1	18.38	16.74	15.20	10.58	9.14	3.29	2.67	1.03	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.73	5.24	5.24	1.54	1.23	1.23	0.62	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	17.84	21.41	14.27	3.57	11.89	1.19	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	73.04	13.37	14.14	10.06	11.16	4.97	3.43	0.00	3.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	73.07	13.35	10.32	11.77	11.05	5.34	3.40	0.61	3.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	80.44	15.06	12.83	13.04	13.64	4.95	3.03	0.00	3.64
hepatoma cell line:Li-7	10484-107A7	14.90	6.56	5.45	4.78	2.45	0.33	0.22	0.22	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	84.62	26.73	21.81	20.30	15.58	8.34	3.92	0.70	2.81
hippocampus - adult, donor10196	10169-103B7	17.98	17.98	8.52	1.89	1.89	4.73	4.73	0.00	2.84
hippocampus, adult, donor10252	10153-102I9	40.21	14.70	5.10	4.90	4.49	11.84	9.39	2.04	1.02
hippocampus, adult, donor10258	10374-105G5	13.44	11.95	0.50	1.00	0.00	4.98	1.00	0.50	1.49
hippocampus, newborn, donor10223	10363-105F3	8.46	4.93	2.47	0.00	3.88	1.06	1.76	0.70	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	117.80	28.08	6.71	7.32	4.88	3.66	3.05	0.00	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	66.56	7.07	4.91	3.93	3.53	4.71	3.34	0.20	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	66.01	9.39	6.86	0.76	3.81	2.79	0.51	0.00	2.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	7.89	16.92	10.15	3.38	5.64	1.69	0.00	0.56	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	18.85	26.08	14.98	11.88	9.30	1.55	1.81	0.52	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	16.70	22.78	11.77	2.66	7.59	2.66	1.14	0.00	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	15.47	17.23	20.14	5.55	18.69	4.38	1.17	1.17	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	19.39	22.40	21.54	12.71	19.17	2.15	2.15	0.86	6.68
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	11.26	16.68	18.77	5.00	14.60	0.42	0.83	0.42	2.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	44.75	28.42	28.42	9.47	24.86	3.08	1.42	0.00	9.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.34	20.25	26.20	13.50	28.29	1.77	0.80	0.16	8.04
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	31.65	20.87	21.55	12.79	19.53	0.67	0.67	0.00	6.06
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	67.29	10.48	6.57	3.29	4.07	3.60	2.66	0.16	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	72.71	10.81	6.39	3.93	5.90	5.40	3.93	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	109.97	13.96	8.73	0.87	13.96	3.49	1.75	0.87	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	17.95	25.96	19.66	13.36	11.45	2.86	0.95	0.19	4.96
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	20.06	35.32	14.39	11.34	9.16	1.31	2.18	1.31	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	21.99	39.48	15.99	11.49	13.49	2.50	1.00	0.50	6.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.61	19.97	18.09	11.87	13.75	1.70	1.32	0.19	5.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.18	21.37	15.01	16.82	18.64	0.91	1.36	0.00	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.20	25.06	15.04	5.33	13.78	0.94	2.19	0.31	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	14.53	21.56	23.19	12.08	25.64	0.82	0.98	0.00	6.04
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	12.77	14.52	17.71	11.32	20.90	0.87	0.58	0.00	5.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.37	16.44	17.94	4.48	14.95	0.30	1.20	0.00	3.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	79.26	9.98	7.21	4.06	6.84	3.33	3.69	0.00	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	62.48	9.98	6.56	3.71	5.42	2.28	1.14	0.29	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	96.77	13.07	7.76	2.04	6.53	1.22	2.45	0.41	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	25.00	18.66	14.79	9.15	14.79	4.93	1.41	0.70	6.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.87	22.49	9.50	8.55	6.65	1.58	0.32	0.95	5.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.07	17.55	13.01	3.03	10.89	1.51	1.21	0.00	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	21.72	18.10	9.31	14.48	4.14	3.10	0.00	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.95	18.60	10.63	9.96	9.96	1.33	0.66	0.00	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.88	12.83	14.11	3.33	14.11	0.26	0.26	0.26	4.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	23.01	15.59	17.38	5.88	19.68	0.77	0.51	0.00	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	18.93	18.93	10.60	21.20	0.76	0.76	0.00	7.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.20	11.76	21.51	3.70	19.49	0.67	0.00	0.00	4.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	76.56	12.32	5.80	3.38	7.00	2.42	1.69	0.00	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	86.90	12.03	11.14	1.78	3.57	3.12	1.34	0.89	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	58.54	12.20	4.88	0.98	4.39	2.93	1.46	0.00	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	22.92	23.53	11.31	9.17	11.92	2.75	1.53	1.22	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	322.07	273.27	188.69	74.82	136.64	26.03	6.51	3.25	71.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	32.10	33.43	15.22	6.62	14.89	1.32	1.65	0.66	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.06	28.46	24.08	8.21	18.61	3.28	3.28	0.00	6.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.48	19.18	14.84	5.43	12.67	1.09	0.72	0.36	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	21.00	18.86	14.59	3.56	13.52	0.71	1.07	0.00	5.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	17.90	22.67	21.48	8.35	27.45	0.00	0.00	0.00	15.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	43.20	32.91	36.84	17.33	31.69	1.76	3.52	0.00	10.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	25.59	17.51	26.40	5.93	18.05	0.81	1.08	0.00	7.00
immature langerhans cells, donor1	11904-125F5	21.55	8.23	14.29	5.81	8.96	1.70	0.73	0.97	3.87
immature langerhans cells, donor2	11905-125F6	13.47	5.54	5.54	3.17	6.34	0.00	0.00	0.79	2.38
insula, adult, pool1	10039-101F3	32.27	12.11	5.02	2.93	3.03	7.76	11.17	0.57	1.61
keratoacanthoma cell line:HKA-1	10791-110H8	11.71	4.88	0.98	1.30	0.33	3.25	2.28	0.00	0.00
kidney, adult, pool1	10017-101C8	26.53	11.11	6.61	4.51	2.10	2.50	1.90	0.30	0.90
kidney, fetal, pool1	10045-101F9	8.70	8.77	5.38	5.31	3.47	1.63	2.12	0.07	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	55.96	22.72	14.77	9.37	9.52	6.25	3.83	1.14	2.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.50	10.64	2.90	2.35	1.38	1.24	0.28	0.41	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.62	5.14	2.57	1.83	1.28	3.30	0.92	1.10	0.55
left atrium, adult, donor1	10079-102A7	5.99	8.72	5.99	1.63	3.27	2.72	1.09	0.54	0.54
left ventricle, adult, donor1	10078-102A6	5.56	10.62	3.54	5.06	4.55	1.52	1.52	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	61.02	11.49	12.31	9.03	16.69	2.19	0.82	1.92	4.92
leiomyoma cell line:10964C	10569-108B2	4.31	0.36	0.36	1.08	0.72	0.36	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	5.43	1.63	0.54	0.00	0.00	0.54	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	9.23	3.89	2.91	1.70	0.97	0.24	0.00	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	32.41	7.32	1.05	5.23	3.14	1.05	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	62.57	26.56	17.71	17.24	9.68	2.48	2.72	0.35	2.83
liposarcoma cell line:KMLS-1	10782-110G8	16.56	4.84	3.91	2.97	3.28	1.41	0.94	0.62	0.94
liposarcoma cell line:SW 872	10726-110A6	19.62	8.29	3.90	2.68	2.31	2.19	0.85	0.73	0.12
liver, adult, pool1	10018-101C9	13.78	5.51	4.21	2.59	3.08	1.30	0.81	0.16	0.32
liver, fetal, pool1	10086-102B5	7.53	2.82	2.82	2.82	0.94	0.94	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	33.10	9.62	4.52	2.19	6.85	6.56	7.29	1.31	1.60
locus coeruleus, adult, donor10252	10165-103B3	34.88	9.97	2.03	3.32	3.14	8.86	9.41	1.29	0.55
locus coeruleus, adult, donor10258	10375-105G6	12.98	5.08	2.54	2.26	2.26	3.95	1.97	0.00	1.13
locus coeruleus, newborn, donor10223	10362-105F2	19.35	7.57	3.36	1.26	3.79	1.26	2.52	0.84	2.94
lung adenocarcinoma cell line:A549	10499-107C4	33.91	11.90	3.04	4.43	1.94	2.21	2.35	0.28	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	7.58	2.07	5.52	3.45	2.76	0.69	3.45	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	29.53	6.33	5.01	2.37	3.16	2.37	2.64	1.05	0.92
lung, adult, pool1	10019-101D1	16.07	11.58	5.79	5.67	2.84	3.07	3.78	0.47	0.83
lung, fetal, donor1	10068-101I5	58.51	34.25	25.40	10.85	10.56	6.56	11.70	0.29	1.43
lung, right lower lobe, adult, donor1	10075-102A3	8.25	5.04	2.75	1.37	1.37	1.37	0.92	0.00	0.92
lymph node, adult, donor1	10077-102A5	7.57	7.57	2.84	5.21	3.31	0.95	2.37	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	150.36	36.82	16.88	19.73	7.67	16.88	8.55	3.95	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	79.54	22.94	11.92	16.90	10.26	3.62	1.21	2.87	3.47
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	66.26	5.10	0.85	1.70	5.10	6.80	3.40	0.00	0.85
mature adipocyte, donor1	12231-129F8	10.21	3.11	0.00	0.44	0.44	0.44	2.22	0.00	0.00
mature adipocyte, donor2	12232-129F9	8.51	2.28	1.04	0.83	0.21	0.62	2.28	0.21	0.00
mature adipocyte, donor3	12233-129G1	9.72	3.56	1.19	0.71	0.00	0.95	2.13	0.24	0.00
mature adipocyte, donor4	12234-129G2	13.16	3.95	2.11	1.32	0.26	1.05	3.42	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	32.88	13.82	4.53	3.81	1.19	9.77	5.00	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	21.43	1.13	0.00	2.26	9.02	7.90	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	25.01	10.48	2.94	4.41	3.13	9.20	6.44	1.66	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	11.44	11.75	2.54	3.18	1.27	4.77	2.54	0.32	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	29.85	10.24	6.40	1.71	5.54	1.71	2.99	0.00	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	22.28	12.66	5.57	4.39	5.40	7.26	9.11	0.34	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	29.50	11.67	2.76	3.82	2.12	10.82	7.00	0.85	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	13.48	7.71	0.00	0.00	3.85	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	588.50	330.13	28.71	43.06	28.71	100.48	172.24	0.00	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	9.69	5.38	2.15	1.08	3.23	1.08	1.44	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	26.61	13.63	2.60	1.95	1.30	9.73	8.44	0.65	1.30
medulla oblongata, adult, donor10252	10155-103A2	36.69	9.75	3.87	3.87	2.01	12.38	12.38	1.08	0.46
medulla oblongata, adult, pool1	10038-101F2	35.92	12.41	4.24	3.02	3.84	10.04	8.57	0.49	1.47
medulla oblongata, newborn, donor10223	10361-105F1	8.68	5.21	2.08	0.00	1.74	0.69	0.69	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	165.39	31.22	21.03	10.41	15.94	12.62	5.31	0.44	7.75
medulloblastoma cell line:ONS-76	10759-110E3	73.98	17.49	7.83	9.66	6.85	4.77	3.79	0.86	0.86
melanoma cell line:COLO 679	10514-107E1	36.37	7.33	5.75	4.31	2.44	3.16	2.73	0.29	1.01
melanoma cell line:G-361	10465-106H6	16.56	11.40	2.71	3.53	0.54	2.99	2.99	0.81	0.54
meningioma cell line:HKBMM	10691-109F7	7.06	1.27	1.27	1.45	0.72	1.45	1.63	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	59.04	30.84	12.34	12.34	6.17	7.93	3.52	0.00	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	69.99	26.44	11.15	5.44	6.48	7.00	2.59	0.00	2.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	30.53	6.60	3.38	3.53	3.99	0.61	1.07	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.63	2.73	2.91	3.09	2.91	0.36	0.55	0.18	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.12	4.97	1.66	1.66	1.66	0.83	0.83	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.57	3.23	2.11	2.95	1.55	1.12	0.70	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.86	3.47	2.70	2.70	1.73	0.19	0.39	0.00	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	4.86	1.39	2.08	0.00	0.69	0.00	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.87	1.03	0.69	0.51	0.34	0.17	0.34	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.25	3.22	2.19	1.73	0.58	0.23	0.35	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.67	5.57	3.98	4.38	3.45	1.33	1.06	0.13	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.17	5.81	2.97	3.11	2.16	0.68	1.35	0.14	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	36.13	6.54	2.13	3.41	1.99	1.71	1.99	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.95	3.95	1.32	0.99	0.33	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.23	5.53	3.46	4.29	3.32	0.83	1.52	0.14	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.45	8.73	2.44	1.05	1.05	2.09	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	15.72	4.29	2.04	2.65	1.22	1.22	0.61	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.91	5.03	1.80	1.08	0.36	1.08	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.59	3.10	2.28	1.55	1.34	0.41	0.21	0.10	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.07	2.28	0.23	0.91	0.00	0.00	0.68	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	64.19	12.17	7.55	7.97	5.03	2.52	1.26	0.42	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.23	3.89	1.05	3.44	1.34	0.90	1.05	0.15	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	13.83	4.20	1.31	2.54	1.58	0.96	1.05	0.09	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	10.31	2.95	2.21	0.74	0.74	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.87	1.72	3.43	1.43	0.86	0.29	0.29	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	68.63	7.58	10.53	3.37	7.16	0.84	0.00	1.68	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	4.11	1.37	0.00	1.83	0.00	0.91	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.58	3.07	2.56	1.28	1.53	0.26	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.42	3.14	1.83	0.79	2.09	0.26	0.52	0.00	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.09	2.16	3.08	0.92	1.85	0.31	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.18	3.53	3.53	1.88	1.18	0.00	0.47	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.48	4.06	1.02	1.35	1.69	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.40	3.54	3.14	1.18	2.36	0.00	0.79	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	9.27	2.78	1.85	0.46	1.85	0.93	1.39	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.69	3.75	1.73	1.15	1.44	0.29	0.58	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.49	3.57	1.56	1.34	1.12	0.22	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.06	5.05	2.40	1.44	1.92	0.72	0.72	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	10.27	3.67	2.20	2.93	2.93	1.47	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.40	2.01	2.01	1.34	0.00	0.34	1.01	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.23	4.09	2.87	1.64	0.41	0.41	0.82	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.88	4.30	1.72	0.43	1.72	1.72	0.86	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	5.47	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	7.79	2.60	0.00	0.97	1.30	0.32	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	2.91	0.00	2.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	2.67	1.07	1.07	1.60	1.07	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	2.45	0.82	0.82	1.64	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.66	1.94	1.94	0.39	0.78	0.00	0.39	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	1.99	0.99	0.99	0.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	0.59	2.96	0.59	2.37	0.59	1.19	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	0.00	1.22	0.00	2.44	0.00	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	1.90	2.53	0.00	1.27	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	2.76	1.03	0.69	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	6.45	4.30	2.15	0.00	0.00	0.00	0.00	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	3.99	0.00	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	1.22	0.81	0.00	0.00	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1.59	0.00	0.00	2.38	0.00	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	0.00	0.00	0.00	0.00	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	3.12	1.25	0.62	0.31	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	2.67	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	1.18	1.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	2.57	0.00	2.57	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	3.44	1.38	0.69	0.00	0.69	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.95	0.00	0.00	0.49	0.00	0.99	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	1.12	1.12	0.00	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	3.82	1.27	0.00	0.64	0.64	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.01	0.00	0.81	0.00	0.00	0.40	1.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	0.00	0.00	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.07	1.21	1.82	0.00	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2.47	1.65	0.00	0.00	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.56	1.98	0.20	0.00	0.20	0.20	0.60	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	2.27	0.97	0.97	0.32	0.00	0.00	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	3.06	2.04	1.02	1.02	0.00	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.83	0.77	0.00	0.77	0.00	2.32	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.72	4.96	3.54	3.31	1.18	5.67	2.13	1.42	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	32.90	9.27	7.65	1.62	4.63	2.55	1.39	0.00	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	4.27	17.09	0.00	0.00	4.27	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	46.85	7.40	7.50	4.52	6.88	1.64	0.51	0.41	1.44
mesothelioma cell line:Mero-25	10850-111F4	17.93	1.59	2.04	0.91	1.13	0.68	0.23	0.45	0.91
mesothelioma cell line:Mero-41	10851-111F5	32.27	6.60	5.87	1.47	3.42	1.47	0.73	0.73	1.71
mesothelioma cell line:Mero-48a	10852-111F6	46.72	7.53	3.54	2.44	2.21	2.21	1.55	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	33.38	7.10	4.20	1.31	5.52	1.84	0.79	1.05	0.79
mesothelioma cell line:Mero-83	10854-111F8	35.75	6.47	4.77	2.38	4.94	0.85	0.68	0.17	1.53
mesothelioma cell line:Mero-84	10855-111F9	13.40	3.54	1.77	0.76	1.26	1.52	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	32.09	7.66	4.14	2.48	3.73	1.45	1.66	0.62	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	25.68	2.82	0.99	0.50	1.33	1.49	0.66	1.33	0.66
mesothelioma cell line:NCI-H226	10846-111E9	15.57	4.71	1.99	0.90	1.45	0.54	0.90	0.00	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	33.82	7.35	2.56	1.37	1.71	0.51	0.68	0.34	0.51
mesothelioma cell line:NCI-H28	10845-111E8	47.08	11.20	7.89	2.54	4.83	2.29	1.53	2.54	0.76
mesothelioma cell line:No36	10857-111G2	58.72	3.59	1.96	0.33	1.30	3.59	1.96	0.00	0.98
mesothelioma cell line:ONE58	10858-111G3	17.61	2.17	1.08	0.27	0.81	0.27	0.27	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	37.42	18.04	5.18	3.45	1.73	3.45	3.26	4.22	0.58
migratory langerhans cells, donor2	11902-125F3	21.00	8.30	2.81	1.95	0.98	1.10	2.32	1.95	0.85
migratory langerhans cells, donor3	11903-125F4	19.74	10.59	6.46	3.95	1.79	0.54	1.62	3.77	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.34	6.86	8.49	2.94	2.29	2.29	0.00	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.90	7.42	4.24	3.39	6.57	1.27	0.42	0.00	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	43.77	14.74	6.91	3.23	2.76	4.84	2.07	0.23	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	55.95	15.60	8.94	7.23	5.52	1.52	1.52	1.52	2.66
myelodysplastic syndrome cell line:SKM-1	10772-110F7	220.27	41.02	45.46	29.20	25.32	7.58	5.54	5.73	5.54
myeloma cell line:PCM6	10474-106I6	25.50	10.08	12.45	5.73	6.72	2.77	0.40	3.56	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.96	15.73	6.59	4.57	10.15	2.03	1.01	0.00	3.55
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.47	5.69	1.57	1.57	0.98	3.53	1.57	0.78	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.25	2.67	0.67	1.56	0.67	1.23	0.78	0.00	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.02	2.94	0.96	1.54	0.37	1.18	1.32	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	33.12	1.66	0.55	1.10	1.66	3.86	2.21	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	55.44	13.11	4.14	5.52	2.53	6.67	5.98	0.00	1.15
neuroblastoma cell line:NB-1	10539-107G8	463.60	96.72	43.03	32.93	23.01	34.80	39.29	0.94	10.66
neuroblastoma cell line:NBsusSR	10607-108F4	44.08	13.08	6.33	8.01	3.59	2.53	0.21	0.00	2.11
neuroblastoma cell line:NH-12	10555-107I6	60.56	20.13	11.18	15.28	8.76	2.61	3.35	0.37	5.22
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	73.07	63.34	30.36	28.94	22.54	2.85	1.66	0.00	8.07
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	52.74	18.53	12.51	10.77	9.50	3.80	2.06	0.63	2.69
neuroectodermal tumor cell line:TASK1	10774-110F9	33.01	18.52	13.69	12.88	8.65	3.42	2.42	0.20	3.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	26.70	28.61	7.63	12.72	5.72	1.27	2.54	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	22.89	8.52	5.86	5.06	6.39	1.06	0.27	0.00	2.93
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	39.84	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	186.71	45.32	20.97	20.13	9.81	21.65	10.15	4.57	1.86
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	89.66	29.62	5.60	12.01	6.40	6.40	4.80	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.73	6.41	2.24	2.56	3.53	0.32	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.99	2.36	2.89	1.05	2.36	0.79	0.53	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	37.40	16.78	3.09	3.37	2.34	9.56	8.53	0.56	1.03
occipital cortex - adult, donor10196	10172-103C1	32.97	10.30	2.06	6.18	4.12	14.42	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	27.64	8.86	1.88	4.03	2.15	11.27	10.47	1.07	1.34
occipital cortex, newborn, donor10223	10355-105E4	5.10	2.18	1.09	0.36	1.46	0.36	0.36	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	16.01	9.45	4.46	2.89	3.15	3.15	4.72	0.26	0.79
occipital lobe, fetal, donor1	10073-102A1	5.58	5.15	3.00	1.29	4.29	0.86	1.29	0.00	1.72
occipital pole, adult, pool1	10036-101E9	9.07	5.44	1.73	1.50	0.55	3.23	3.55	0.32	0.24
olfactory region, adult	10195-103E6	26.56	14.14	5.16	4.97	1.72	7.64	5.73	0.76	0.57
optic nerve, donor1	10277-104E7	16.01	12.01	4.00	4.00	4.00	4.00	4.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	51.26	5.35	2.96	2.28	2.05	2.05	0.91	1.71	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.01	4.40	0.55	1.51	0.27	4.40	2.75	0.55	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.55	10.33	8.97	3.22	3.89	3.39	2.03	0.00	1.69
oral squamous cell carcinoma cell line:SAS	10544-107H4	39.50	5.54	5.89	2.66	1.50	3.12	2.66	0.12	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	20.28	2.65	1.76	0.29	0.29	1.76	0.00	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	99.04	34.57	18.69	12.15	10.28	15.88	9.34	0.93	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	85.67	18.66	20.15	9.54	10.39	3.61	3.39	0.64	2.33
ovary, adult, pool1	10020-101D2	22.54	10.48	8.65	6.20	5.15	4.37	2.71	0.26	1.22
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.85	16.13	6.78	7.88	6.42	2.75	2.02	1.47	0.55
pancreas, adult, donor1	10049-101G4	6.58	0.00	2.82	0.94	3.76	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	21.24	11.74	8.11	6.15	5.03	3.63	1.68	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	18.57	3.07	2.90	0.85	0.85	1.19	1.36	0.51	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	16.89	3.97	4.31	1.99	1.66	1.82	1.99	0.00	0.50
paracentral gyrus, adult, pool1	10035-101E8	28.01	12.81	4.12	3.11	1.74	8.15	10.80	0.37	1.01
parietal cortex, adult, donor10258	10373-105G4	27.16	11.01	3.67	0.00	0.00	3.67	3.67	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	10.35	4.70	0.00	4.70	6.58	11.29	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	23.94	11.40	5.13	5.13	2.00	10.55	7.41	1.43	0.86
parietal lobe, adult, pool1	10034-101E7	21.32	7.40	2.47	2.64	1.85	5.82	6.70	0.88	0.62
parietal lobe, fetal, donor1	10072-101I9	18.43	6.79	8.73	4.85	11.64	2.91	1.94	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	8.97	1.87	1.50	0.37	2.62	1.87	2.62	0.00	1.50
parotid gland, adult	10199-103F1	5.55	3.08	1.23	3.08	0.62	0.62	1.85	0.00	0.62
penis, adult	10200-103F2	11.28	6.45	3.76	2.15	1.07	2.69	2.69	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.34	15.80	6.69	4.28	2.79	1.12	0.19	0.19	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.11	3.21	3.50	1.31	0.73	2.91	2.48	0.29	0.44
pineal gland - adult, donor10196	10179-103C8	29.03	15.48	5.81	4.52	3.23	16.77	9.68	0.65	2.58
pineal gland, adult, donor10252	10160-103A7	93.57	33.16	10.07	21.91	4.15	27.83	34.35	0.59	4.74
pineal gland, adult, donor10258	10377-105G8	16.93	23.83	6.90	4.39	2.51	3.14	8.78	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	30.35	9.11	2.02	1.01	2.02	10.12	4.05	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	42.22	9.38	3.65	4.69	1.56	16.16	19.80	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	12.77	6.81	1.70	0.00	0.00	4.26	2.55	0.85	1.70
placenta, adult, pool1	10021-101D3	10.21	4.52	2.69	3.23	1.51	0.75	1.83	0.11	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	70.45	19.47	9.67	8.34	6.09	7.68	4.11	3.71	1.99
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.61	4.82	2.33	3.74	1.71	0.47	1.25	0.78	0.62
pons, adult, pool1	10033-101E6	32.88	12.14	4.13	4.13	2.15	10.33	9.55	0.77	1.55
postcentral gyrus, adult, pool1	10032-101E5	14.47	7.76	2.44	1.31	1.57	3.57	4.53	0.26	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	4.18	0.00	0.00	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	11.02	22.03	11.02	11.02	0.00	0.00	5.51	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	197.95	44.14	19.52	14.57	8.01	8.01	6.85	3.50	2.48
prostate cancer cell line:PC-3	10439-106E7	74.78	23.41	13.07	11.62	7.80	9.08	7.99	1.63	2.72
prostate, adult, pool1	10022-101D4	18.14	11.25	5.08	4.26	2.09	3.17	4.26	0.27	0.63
putamen, adult, donor10196	10176-103C5	51.93	24.79	8.03	8.97	4.25	14.87	14.87	1.42	3.54
putamen, adult, donor10252	10152-102I8	27.45	7.84	3.92	3.92	0.00	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	77.59	18.58	3.28	1.09	4.37	1.09	2.19	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	23.68	12.08	3.62	1.21	2.90	5.32	5.07	0.24	0.48
putamen, newborn, donor10223	10365-105F5	23.99	10.50	4.50	2.25	6.75	1.50	2.25	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	18.91	18.62	9.60	8.15	3.78	5.24	2.62	0.29	0.58
rectum, fetal, donor1	10067-101I4	12.52	12.52	8.35	8.35	12.52	2.78	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.77	9.96	4.88	2.33	1.91	1.27	2.54	1.27	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.87	17.81	6.21	6.63	1.66	0.41	0.83	1.24	0.41
retina, adult, pool1	10030-101E3	31.21	18.19	9.24	9.05	4.67	6.26	5.57	0.40	1.29
retinoblastoma cell line:Y79	10475-106I7	124.45	69.37	25.20	25.72	9.61	15.07	7.01	0.26	3.64
rhabdomyosarcoma cell line:KYM-1	10787-110H4	57.42	26.68	22.87	15.12	16.97	4.67	1.84	0.49	6.15
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	113.89	64.68	46.96	35.43	30.37	19.68	9.56	0.00	11.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.85	3.03	1.52	1.52	2.27	0.76	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	7.45	4.69	1.62	2.27	1.94	0.81	0.49	0.00	0.32
salivary acinar cells, donor2	11772-123I8	8.26	4.27	2.34	1.24	1.38	1.10	0.69	0.41	0.83
salivary acinar cells, donor3	11773-123I9	7.94	3.97	2.65	2.65	1.99	1.32	1.32	0.66	0.00
salivary gland, adult, pool1	10093-102C3	8.58	7.44	3.43	1.72	1.72	2.86	2.29	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.42	6.58	3.54	1.35	1.60	4.30	5.40	2.19	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	42.91	6.58	2.12	1.76	1.18	3.88	7.05	3.06	0.35
seminal vesicle, adult	10201-103F3	18.52	19.05	14.28	4.76	10.05	2.12	3.17	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.90	3.16	3.16	2.43	2.19	2.92	1.70	1.46	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.81	3.52	0.75	0.25	1.01	0.75	0.00	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	20.07	6.02	1.00	3.01	0.00	0.00	2.01	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.73	2.01	0.81	0.40	0.40	1.61	0.67	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	19.34	6.19	2.32	2.21	1.66	2.43	1.77	0.11	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.35	13.68	4.26	3.87	0.90	0.90	1.94	0.13	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	13.48	24.83	6.38	4.26	11.35	1.42	2.84	0.71	3.55
skeletal muscle, adult, pool1	10023-101D5	13.79	13.91	6.84	5.04	3.48	3.72	2.40	0.12	1.20
skeletal muscle, fetal, donor1	10066-101I3	5.03	5.03	0.00	3.02	4.02	2.01	0.00	0.00	1.01
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	8.84	11.36	7.57	7.57	5.05	1.89	0.63	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	35.69	12.34	4.00	4.34	1.00	5.67	3.67	0.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	64.30	24.90	20.49	13.24	10.40	6.30	4.10	0.32	5.36
small cell lung carcinoma cell line:DMS 144	10841-111E4	44.14	7.52	0.96	2.12	0.77	7.52	5.01	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	259.77	61.98	25.88	28.02	13.19	30.33	22.09	0.66	4.45
small cell lung carcinoma cell line:NCI-H82	10842-111E5	91.04	40.53	7.72	12.22	3.38	30.24	16.89	0.00	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	25.28	16.78	10.24	13.51	4.79	4.79	4.79	0.00	1.96
small intestine, adult, pool1	10024-101D6	22.34	12.78	5.37	5.97	1.91	2.27	2.87	0.12	0.36
small intestine, fetal, donor1	10064-101I1	12.28	14.00	8.85	9.58	6.14	2.70	0.98	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	6.67	6.67	5.13	2.05	0.51	1.03	0.51	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	22.74	17.57	7.75	8.53	5.43	3.62	3.88	0.78	1.81
somatostatinoma cell line:QGP-1	10781-110G7	12.33	13.40	3.75	5.36	1.07	3.48	2.68	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	28.45	21.56	4.59	5.51	8.49	8.72	8.95	0.00	3.21
spinal cord, adult, donor10252	10159-103A6	64.27	25.63	7.49	8.67	5.13	18.53	18.14	2.76	1.97
spinal cord, adult, donor10258	10369-105F9	34.59	20.06	2.08	2.08	3.46	4.15	3.46	1.38	2.08
spinal cord, fetal, donor1	10056-101H2	15.25	9.15	5.49	10.37	1.83	1.22	1.22	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	19.29	12.40	8.27	2.30	5.05	3.67	1.38	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.79	5.53	4.18	2.24	3.14	1.94	1.34	0.30	1.64
spleen, adult, pool1	10025-101D7	23.57	17.51	6.94	6.39	2.97	2.53	3.63	0.66	0.77
spleen, fetal, pool1	10044-101F8	15.73	9.22	5.64	3.89	1.59	1.51	1.19	0.08	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	71.42	25.26	20.29	11.08	10.45	3.73	3.62	2.38	2.38
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.22	13.48	4.94	5.32	1.90	3.80	2.85	0.95	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	44.03	10.48	4.89	6.29	2.45	4.54	2.10	0.00	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.16	4.30	2.74	1.95	4.69	1.56	0.39	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	7.43	7.43	4.95	4.28	1.35	1.35	1.35	0.56	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	25.42	8.47	6.78	1.27	6.78	0.85	0.85	0.00	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	65.15	12.27	6.35	3.81	2.54	1.27	0.85	0.85	2.96
stomach, fetal, donor1	10062-101H8	6.41	12.82	7.48	9.61	2.14	3.20	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	6.27	8.55	2.28	1.71	1.71	1.14	2.85	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	0.00	0.00	54.27	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	32.19	11.01	3.32	4.36	2.49	8.72	7.89	1.25	0.00
substantia nigra, adult, donor10258	10371-105G2	21.21	11.90	1.55	0.00	1.03	2.59	5.17	2.07	1.03
substantia nigra, newborn, donor10223	10358-105E7	12.72	3.53	0.71	0.71	3.53	0.00	0.71	0.00	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	86.43	46.08	30.72	22.47	18.57	2.52	4.59	0.23	5.73
temporal lobe, adult, pool1	10031-101E4	11.02	5.59	1.36	1.86	0.59	2.80	3.48	0.34	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	5.70	3.56	3.56	3.56	1.42	3.56	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.50	3.96	3.52	0.88	3.96	1.76	0.00	0.00	2.64
tenocyte, donor1	11763-123H8	20.25	6.63	4.19	1.75	1.40	1.75	1.75	0.35	0.00
tenocyte, donor2	11765-123I1	9.54	3.43	1.91	0.38	0.38	0.38	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	17.79	4.45	3.34	1.48	2.22	1.85	0.37	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	170.47	65.09	45.55	39.09	36.03	13.09	5.61	1.02	10.37
teratocarcinoma cell line:NCR-G1	10798-110I6	48.86	15.88	14.03	9.25	13.10	6.78	2.00	0.62	4.16
teratocarcinoma cell line:PA-1	10807-111A6	59.82	13.33	6.66	7.28	7.59	5.58	2.17	0.15	2.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	62.08	9.77	2.67	4.44	3.05	2.03	2.16	0.00	2.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	67.69	10.97	6.81	5.67	5.67	6.81	4.92	0.00	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	34.25	9.05	1.85	3.38	1.74	6.00	3.27	0.11	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.33	8.14	5.86	2.61	4.56	5.86	6.51	0.00	0.65
testis, adult, pool1	10026-101D8	12.13	8.38	3.97	3.76	2.68	1.18	1.93	0.32	0.75
testis, adult, pool2	10096-102C6	8.12	5.41	2.26	0.45	0.90	1.35	2.26	0.45	0.00
thalamus - adult, donor10196	10168-103B6	26.50	24.29	4.42	1.10	1.10	13.25	5.52	1.10	1.10
thalamus, adult, donor10252	10154-103A1	37.35	12.66	2.66	4.22	1.56	9.38	9.53	1.72	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	61.58	26.17	7.70	0.00	0.00	6.16	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.25	4.45	2.14	1.32	0.82	2.31	1.32	0.33	0.82
thalamus, newborn, donor10223	10366-105F6	12.08	5.75	2.88	0.58	2.30	2.30	3.45	0.00	1.73
throat, adult	10209-103G2	9.99	6.49	4.24	2.75	1.75	1.50	2.25	0.00	0.75
throat, fetal, donor1	10061-101H7	12.80	6.09	6.09	5.48	6.40	3.66	2.74	0.00	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	31.60	22.66	11.73	6.16	9.34	2.38	2.58	0.40	2.98
thymus, adult, pool1	10027-101D9	95.74	39.57	12.92	14.42	8.65	5.57	3.98	0.60	2.09
thymus, fetal, pool1	10043-101F7	68.27	32.83	14.34	14.23	8.31	5.61	3.32	0.73	2.18
thyroid carcinoma cell line:KHM-5M	10776-110G2	36.43	7.45	3.86	0.66	1.86	2.39	2.79	0.00	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	42.61	11.87	7.96	4.89	3.07	7.54	2.10	0.70	1.54
thyroid, adult, pool1	10028-101E1	12.41	9.24	4.29	4.39	1.96	3.08	4.48	0.28	0.84
thyroid, fetal, donor1	10060-101H6	9.76	8.44	7.12	5.01	2.64	3.16	3.95	0.00	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	12.32	12.32	0.00	3.08	0.00	21.56	0.00	0.00
tongue, adult	10203-103F5	17.68	9.30	3.26	1.16	2.33	1.86	3.26	0.23	1.40
tongue, fetal, donor1	10059-101H5	7.49	11.43	4.73	5.12	3.55	2.76	1.97	0.00	0.79
tonsil, adult, pool1	10047-101G2	24.24	13.02	7.41	6.41	2.60	3.01	4.21	0.50	1.20
trachea, adult, pool1	10029-101E2	18.57	8.43	3.93	3.19	1.88	1.47	2.54	0.82	0.49
trachea, fetal, donor1	10058-101H4	6.54	6.16	5.77	4.23	5.77	2.31	2.31	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	42.16	6.02	6.02	3.54	4.25	0.71	0.35	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	51.37	11.25	7.60	4.96	4.26	3.24	1.62	0.00	1.01
transitional-cell carcinoma cell line:JMSU1	10492-107B6	212.31	23.50	10.65	8.46	3.92	17.24	13.01	1.25	1.57
tridermal teratoma cell line:HGRT	10694-109G1	17.12	5.71	7.61	0.00	3.81	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.80	3.64	2.20	1.61	0.59	1.44	1.35	0.85	0.42
umbilical cord, fetal, donor1	10057-101H3	18.78	2.09	2.09	2.09	6.26	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	25.25	17.40	7.85	6.31	2.22	5.29	4.44	0.00	2.22
uterus, fetal, donor1	10055-101H1	10.24	4.61	8.70	8.70	5.12	2.56	3.07	0.00	1.54
vagina, adult	10204-103F6	8.40	5.17	1.29	5.17	1.94	2.58	3.23	2.58	0.00
vein, adult	10191-103E2	17.76	10.08	4.16	3.51	3.07	1.53	1.53	0.00	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.77	11.48	2.67	5.61	2.94	2.14	2.40	1.07	0.53